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ABSTRACT
The Mo-nitrogenase complex is composed of two components, Fe-protein
and MoFe-protein. This complex is able to catalyze the reduction of N2 through the
MgATP dependent transfer of electrons from the Fe-protein Fe4S4 cluster to the
MoFe-protein P-cluster and, subsequently, to the iron-molybdenum cofactor (FeMoco). FeMo-co is a Fe7S9MoC-(R)-homocitrate cluster and has two biosynthetic
precursors, NifB-co and L-cluster, of unknown structure and composition. The
biosynthesis of FeMo-co is an enigmatic process that minimally requires NifB, NifEN,
Fe-protein, MoO42-, (R)-homocitrate and S-adenolsylmethionine.
A means to isolate the NifB enzyme for characterization has been developed
through use of a GST-fusion tag. Double recombination of A. vinelandii strains with a
constructed vector has yielded strains capable of nif promoter regulated expression
of GST-NifB. Extracts of strains containing GST-NifB were shown to activate the Monitrogenase complex in biochemical complementation assays. Mass spectroscopy
was then used to verify successful isolation of GST-NifB by GSH-Sepharose affinity
purification.
The number of NifB-co ligand binding sites and ligand types were examined
by EXAFS analysis of samples containing selenol and thiol ligands. A Fe6S9C model
for NifB-co was optimized to best fit the EXAFS data, where a 2-fold discrepancy in
binding sites implied by thiol or selenol only ligand samples suggests Fe-(μ2S)-Fe
binding in the absence of Se. Samples containing heterogeneous ligand types
indicated that NifX bound NifB-co ligates to four cysteine residues and one molecule
of DTT.
iii
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CHAPTER 1: INTRODUCTION AND OVERVIEW
Introduction to Nitrogen Fixation
Nitrogen Fixation Is Essential For Life
Nitrogen fixation is the process of reducing atmospheric N2 to NH3. The
reduction of N2 to NH3 is essential for life, because NH3 is the major bioavailable
form of nitrogen. Fixed nitrogen is enzymatically incorporated as part of amino
acids, nucleotides and lipid components of the living cell (1). Various diazotrophic
bacteria and archael species provide biologically fixed nitrogen to plants and
marine life in the terrestrial and oceanic biospheres. Phytoplankton that fix
nitrogen on the surface of the oceans are consumed by marine life. Plants that
absorb nitrogen from soil enriched by diazotrophs or form a symbiotic
relationship with diazotrophs are then consumed by animals (Figure 1). Thus, the
N2 reduction activity of diazotrophs is the essential entry point of nitrogen into the
biosphere.
Nitrogen is second to water as the limiting resource for crop yields, and
the future lack of fixed nitrogen is predicted to have dire societal impacts. The
advent of the Haber-Bosch industrial nitrogen fixation process during World War I
has enabled humankind to cultivate the earth and greatly increase crop yields,
resulting in a heavy dependence on the Haber-Bosch process for sustaining the
current population. The Haber-Bosch process reacts N2 and H2 at temperatures
above 300 ⁰C and pressures greater than 150 bar to produce NH3 that is
condensed and incorporated into fertilizers as NH4NO3. The extreme conditions
1

to facilitate industrial nitrogen fixation require tremendous amount of energy,
estimated to consume 3 – 5 % of the yearly global natural gas production or 1 – 2
% of the yearly global energy output. Furthermore, the necessary role of the
Haber-Bosch process in society has led to the acceptance of detrimental
environmental effects caused by the industrialized nitrogen fixation. The
projection of a 30% population growth to 9 billion by 2050 has brought to light the
lack of resources, including fixed nitrogen, required to sustain such an enormous
population (2,3). New research and development on next generation HaberBosch catalysts is required for improving industrialized nitrogen fixation to
alleviate the harmful effects to the environment, to consume less of the world’s
supply of energy, and to sustain the expected boom in human population.
Nature’s paragon of nitrogen fixation is nitrogenase, and fully understanding the
biochemistry of enzymatic nitrogen fixation may provide insight towards
improving industrial nitrogen fixation.

Figure 1 : Nitrogen Assimilation into the Terrestrial Biosphere
The reduction of N2, catalyzed by nitrogenase in diazotrophs, provides fixed nitrogen to plants
and higher organisms through soil enrichment, symbiosis and consumption.

2

Molybdenum Nitrogenase
Biological nitrogen fixation in diazotrophic bacteria is catalyzed by the
nitrogen reduction activity of nitrogenase complex. Diazotrophic bacteria may
contain up to three different nitrogenase systems that vary in the composition of
their active site metal cluster, the most abundant of which is the molybdenum
nitrogenase. This introduction will focus on the molybdenum nitrogenase (Monitrogenase) and associated nitrogenase maturation systems mainly from
Azotobacter vinelandii, unless otherwise noted. A. vinelandii has been used as a
model for Mo-nitrogenase because it is easily cultured. The Mo-nitrogenase
complex consists of two purifiable component proteins. Component II, known as
iron protein (Fe-protein) or dinitrogenase reductase, houses a single Fe-S cluster
and functions to provide electrons to component I. Component I, known as the
molybdenum-iron protein (MoFe-protein) or dinitrogenase, houses two Fe-S
clusters and utilizes the electrons transferred from Fe-protein to catalyze the
reduction of N2. Each Fe-protein turnover requires two molecules of MgATP to be
hydrolyzed in order for one electron to be transferred from the Fe-protein to the
MoFe-protein. Eight turnovers of the Fe-protein are minimally required to
completely reduce a molecule of N2 to two molecules of NH3 and to generate a
molecule of H2 from the obligatory reduction of protons, discussed later. The full
reaction for nitrogen reduction is shown in Equation 1.
Equation 1 : Biological Nitrogen Fixation

(1)
The section below will be organized to describe the Mo-nitrogenase
complex and the properties of the individual components. Description of protein
3

structure, cofactor composition and properties will provide for an understanding
of the Fe-protein turnover cycle, the MoFe-protein, and a putative mechanism for
the reduction of N2 to NH3.
Fe-protein
The Fe-protein component of nitrogenase plays an essential role in both
dinitrogen reduction itself and active site metal cluster biosynthesis.
Developments in the understanding of Fe-protein within the last two decades are
due in large part to electron spectroscopic techniques and X-ray absorption or
diffraction analysis of the stable Mo-nitrogenase complex formed with key single
residue variants of Fe-protein and nucleotide ligand substitutions. A description
of the structure, Fe-S cluster oxidation states and nucleotide binding effects of
the Fe-protein will follow to describe the Fe-protein function and the catalytic
cycle that leads to electron transfer to the MoFe-protein.
Structure
The Fe-protein is a homodimer product of two NifH subunits. Each subunit
of the Fe-protein contains a MgATP binding Walker motif and two cysteine
residues that bind an Fe4S4 cluster found at the interface of the two NifH subunits
(Figure 2). X-ray crystallographic analysis and a series of biochemical
experiments indicated that communication exists between the nucleotide binding
site and the Fe4S4 cluster bound 15 Å away. The mechanism of communication
that relates the status of nucleotide binding to the Fe4S4 cluster occurs through
the interaction of the Walker motif P-loop (GxxxxGKT/S) with Switch I and Switch
II (Figure 2), named due to their structural homology to G-proteins that are also
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nucleotide binding proteins (4). Crystal structure analysis depicted Asp39 of
Switch I and Asp125 of Switch II stabilizing the nucleotide bound Mg2+ ion.
Switch II also contains the Cys132 residue that provides two bonds, one from
each NifH subunit, to the inter-subunit Fe4S4 cluster. Therefore, the charge
interaction between Mg2+ and Asp125 in the presence of bound nucleotide can
be conformationally communicated by the movement of Switch II to sensitively
alter the ligand geometry and structure of the Fe4S4 cluster through Cys132 (5).
The result of this communication is a change in midpoint reduction potential of
the cluster, which will be elaborated upon later. Conformational communication is
also understood to be important in electron transfer, as evidenced by the site
directed mutagenesis of the P-loop Lys15 to Gln. This K15Q Fe-protein variant
was found to be incapable of electron transfer to the MoFe-protein, as seen by
the lack of acetylene reduction activity in the presence of an active MoFe-protein
partner. The wildtype Fe-protein in the presence of MoFe-protein is able to
catalyze the two electron reduction of acetylene to ethylene but the K15Q Feprotein is unable to catalyze reduction. While the K15Q Fe-protein is unable to
catalyze the reduction of substrates, it is still able to bind ATP. Binding
experiments were performed by gel filtration chromatography with ATP in the
mobile phase buffer, with or without MgCl2. Comparative HPLC analysis of
solutions, that were retained after the gel filtration protein fractions were acid
precipitated and pelleted, indicated that K15Q still binds to nucleotides (6). This
then implies that the charge or length of Lys15, which is subtly absent in Gln,
plays some role in the docking of Fe-protein to MoFe-protein or communication
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between nucleotide and cluster that leads to electron transfer. One possibility is
the formation of a reversible salt bridge between Lys15 and Asp125 of Switch II
that could be broken upon association with nucleotide, resulting in the lack of
conformational communication with the cluster through Cys132 as mentioned
before.

Figure 2 : Diagram of Pertinent Peptides and Ligands within the Fe-protein (7)
Peptide backbones are depicted as individual tubes in different shades of green. Atoms are grey
for C, blue for N, red for O, pink for P, yellow (big) for Mg, yellow (small) for S, and green for Fe.

Fe4S4 Oxidation States
As mentioned above, each NifH subunit of Fe-protein contains two
cysteine residues, Cys132 of Switch II and Cys97 (Figure 2), that ligate to the
Fe4S4 cluster. This cluster and the clusters of MoFe-protein have a free energy
difference (ΔG) upon changes in oxidation states as measured by midpoint
reduction potential. To understand how this energy difference upon redox is used
towards the reduction of substrates, the oxidation states of the clusters must be
6

characterized. Mössbauer and electron paramagnetic resonance (EPR)
spectroscopic analysis revealed that the as-purified Fe-protein, in the presence
of dithionite, contains a [Fe4S4]1+ cluster exhibiting mixed electronic spin states.
The [Fe4S4]1+ cluster produces an EPR signal containing both an S = 1/2 spin
with g = 1.92 and an S = 3/2 spin with g value around 5. Interestingly, the
contribution of each spin state to the total signal can be shifted to comprise
mostly of the S = 1/2 when in 50% ethylene glycol or S = 3/2 when in 0.4 M urea,
indicating that the [Fe4S4]1+ cluster is open to solvent interaction that can affect
its electronic spin alignments. A second oxidation state was identified when Feprotein was passed through a size exclusion column, to remove dithionite,
followed by chemical oxidation with the addition of thionine or enzymatic
oxidation resulting from interaction with MoFe-protein. The oxidized form of the
Fe-protein was observed to be spin silent by EPR analysis, whereas
characterization by Mössbauer indicates the presence of two Fe3+ and two Fe2+,
thus confirming the Fe4S4 cluster to be in the diamagnetic 2+ oxidation state (8).
A third oxidation state that is more reduced than the [Fe4S4]1+ is also possible
with addition of very strong reducing agents such as Ti(III)citrate. Mössbauer
characterization of the Fe-protein treated with Ti(III)citrate results in an all Fe2+
[Fe4S4]0 cluster, but this state is not likely to be physiologically relevant due to the
required extremely low reduction potential as mentioned below.
The free energy difference upon the 2+ to 1+ redox change of the Fe 4S4
cluster of Fe-protein is thought to be transferred to the MoFe-protein.
Measurement of the midpoint potential for the [Fe4S4]2+/1+ redox couple was
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performed by controlled potential microcoulometry of Fe-protein samples titrated
with redox dyes such as indigosulfonate or methylene blue. The [Fe4S4]2+/1+
redox couple was measured to be -300 mV vs. NHE (9). Similar microcoulometry
measurements of Fe-protein treated with Cr(III)citrate indicate a -790 mV vs.
NHE midpoint reduction potential for the [Fe4S4]0/1+ redox couple (10). Recently,
extended X-ray absorption fine structure (EXAFS) and nuclear resonance
vibrational spectroscopy (NRVS) was used to probe the structural differences in
the three different oxidations of the Fe-protein Fe4S4 cluster. The symmetric FeFe distances of the cubane [Fe4S4]2+ structure become stretched with each
reduction to the 1+ and 0 oxidation states. At the same time, the Fe-Cys bond
was observed to be an interaction with a large force constant. These results
imply that the surrounding peptide environment may influence the structure, and
therefore the oxidation state, of the Fe4S4 cluster through the ligated Cys
residues (11).
Effects of Nucleotide Binding
Each of the Walker motif P-loops within the NifH subunits in Fe-protein
can bind a nucleotide. Nucleotide binding initiates conformational changes that
lead to the eventual transfer of an electron from Fe-protein to MoFe-protein. For
the likely purpose of being energy efficient in the form of reducing potential, the
binding of MgATP should occur prior to the reduction of the Fe4S4 cluster.
Indeed, Isothermal Titration Calorimetry (ITC) analysis has revealed that MgATP
binds to Fe-protein containing [Fe4S4]2+ with higher affinity (Kd1ATP/2+ = 45 μM)
than to Fe-protein containing [Fe4S4]1+ (Kd1 ATP/1+ = 500 μM). Similarly, MgADP
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binds to the Fe-protein containing [Fe4S4]2+ with higher affinity (Kd1 ADP/2+ = 43 μM)
than to Fe-protein containing [Fe4S4]1+ (Kd1 ADP/1+ = 330 μM). In addition, the Feprotein exhibits nucleotide cooperativity as evidenced by a higher affinity for the
second nucleotide (Kd2ATP/2+ = 10 μM, Kd2ADP/2+ = 8.1 μM) (12). Higher affinity for
the oxidized state and nucleotide cooperativity corroborate the idea that Fe
protein utilizes nucleotide binding to prevent the misuse of reductive equivalents
that correspond to the redox of the cluster. Measurements indicated a -120 mV
decrease in the midpoint reduction potential of the [Fe4S4]2+/1+ redox couple with
the addition of MgATP or MgADP (13). This decreased reduction potential
suggests that, in the presence of nucleotides, the [Fe4S4]1+ state is able to act as
a more powerful reductant corresponding to a larger yield of free energy upon
oxidation. To understand how Fe-protein is able to use nucleotide binding to
control redox properties of the cluster, the cluster specific structural changes that
may occur upon nucleotide binding needed to be characterized.
As mentioned above, one path of conformational communication between
nucleotide and cluster could reside in the Switch II peptide segment containing
Asp125 and Cys132. This peptide segment was characterized for nucleotide
binding induced conformational changes by site directed mutagenesis of Asp125
Glu, a substitution that effectively lengthens the carboxylate chain at that residue
position. As with the K15Q variant of Fe-protein, the D125E variant also appears
to be defunct in acetylene reduction activity yet retains the ability to bind
nucleotides. Interestingly, incubation of the D125E variant with α,α-bipyridyl
resulted in Fe chelation with decomposition of the Fe4S4 cluster. This is a
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characteristic exhibited only by MgATP bound Fe-protein likely due to
conformational changes that expose the cluster to solvent interaction such as
ethylene glycol and urea during EPR characterization. This is possibly explained
by the longer carboxylate chain in Glu binding to the β- or α-phosphoryl group of
MgADP to induce conformational changes that mimic the γ-phosphoryl
interaction with Asp (14).
In addition to binding MgATP, hydrolysis is also required for substrate
reduction by the Mo-nitrogenase complex (15). This was corroborated by crystal
structures of non-dissociating Mo-nitrogenase complexes formed by MoFeprotein incubation with either a ΔLeu127 Fe-protein variant (13) or wild type Feprotein in the presence of MgADP and AlF4- (16,17). Leu127 is also located in
Switch II along with Asp125 and Cys132. ΔLeu127 Fe-protein is locked in a
conformational state that allows for the docking to MoFe-protein but prevents
electron transfer and dissociation. The ΔLeu127 peptide likely mimics the taut
Switch II state formed by Asp125 interaction with bound MgATP and therefore
suggested that nucleotide dependent Switch II conformational changes are
significant for docking onto MoFe-protein. In agreement with this was the AlF4- ●
MgADP bound based non-dissociating Mo-nitrogenase complex that did not
allow for the reduction of substrates. Here, AlF4- and MgADP mimic the
conformational change that MgATP induces on Switch II through Asp125.
However in this case, Fe-protein retains Switch II conformational freedom
through the presence of Leu127 but still is unable to transfer electrons and
dissociate from the Mo-nitrogenase complex. This therefore suggests that the
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hydrolysis of MgATP, which cannot be mimicked by AlF4- and MgADP, is
significant for electron transfer and dissociation (16,17).
Turnover Cycle for Electron Transfer
The Fe-protein functions as an electron donor to both MoFe-protein during
substrate reduction and to NifEN during maturation of the active site metal cluster
within MoFe-protein. The MoFe-protein associated Fe-protein turnover can be
summarized with the following events: 1) Fe-protein bound to MgATP and
[Fe4S4]1+ is in a conformational state that allows for docking onto MoFe-protein
(Figure 3a). 2) Hydrolysis of MgATP to MgADP and electron transfer from the Feprotein [Fe4S4]1+ to the P-cluster in the MoFe-protein occurs in an unknown order
or possibly simultaneously (Figure 3b). 3) Conformational changes induced by
MgADP and [Fe4S4]2+ result in disassociation of Fe-protein from MoFe-protein
(Figure 3c). 3) Replacement of MgADP bound on Fe-protein with MgATP (Figure
3d). 4) Finally, reduction of the Fe-protein [Fe4S4]2+ to a [Fe4S4]1+ state (Figure
3e) possibly by ferrodoxin or flavodoxin (18,19) to arrive at the first step. This
process is likely the same in the Fe-protein’s interaction with NifEN due to NifEN
and MoFe-protein similarities.
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Figure 3 : Fe-protein Turnover Cycle with MoFe-protein
Fe-protein is depicted as two green NifH subunits while half of the MoFe-protein is depicted as a
pair of magenta and blue boxes. The yellow box housed in Fe protein represents the Fe4S4
cluster and contains a number to indicate the oxidation state of the cluster. The yellow rectangle
N
within MoFe-protein represents P-cluster and is labeled P for the as-purified oxidation state and
?
P for the unknown oxidation state after electron relay to FeMo-co. The green circle within MoFeN
R
protein represents FeMo-co and is labeled M for the as-purified oxidation state and M for the
reduced state after electron relay from P-cluster. The process depicted here is likely the same for
the Fe-protein interaction with NifEN.

Molybdenum-Iron Protein
Recent developments in X-ray emission spectroscopy (XES) have led to
the full compositional characterization of the MoFe-protein active site metal
cluster, FeMo-co. In addition, advancements in electron spectroscopies and
recent characterizations of freeze trapped MoFe-protein in mid-turnover has
provided insight towards the mechanism of N2 reduction and brought forth a draft
mechanism of the Mo-nitrogenase complex. This section will describe the
structure and oxidation states of MoFe-protein and its clusters prior to an
overview of the “draft” mechanism.
Structure
The MoFe-protein is the heterotetrameric product of the NifD, α-subunit,
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and NifK, β-subunit, proteins (Figure 4A). Crystal structure analysis reveals a
Fe8S7 cluster, named P-cluster, at the α- and β-subunit interface approximately
15 Å from the Fe-protein docking surface. The structure of the P-cluster can be
described as two cubane Fe4S4 clusters of which six Fe atoms are connected by
a single μ6 S atom and two Fe atoms sit at the terminal ends (Figure 5B) (20).
The two halves of the P-cluster are also bridged by two μ2 S atoms from cysteine
residues, Cys88 of the α-subunit and Cys95 of the β-subunit. The P-cluster is
thought to function as an electron relay cluster between the Fe-protein Fe4S4
cluster and the second MoFe-protein metal cluster, FeMo-co.

Figure 4 : Diagram of Mo-nitrogenase Complex and Cofactors
Shown in (A) is the ribbon diagram for half of the Mo-nitrogenase complex derived from PDB
1G21 (21). The MoFe-protein α-subunit is in blue and β-subunit is in magenta. Fe-protein is
shown docked as two green NifH subunits. On the right in (B) are the cofactor inter-workings of
the Mo-nitrogenase complex. Atoms are grey for C, blue for N, red for O, solid pink for P, big pink
shells for Mg, yellow for S, purple for Mo, and green for Fe

Crystal structures locate FeMo-co within the α-subunit about 10 Å from the
P-cluster. The structure of FeMo-co can also be thought of as two cubane Fe4S4
clusters where one terminal Fe atom is replaced by a Mo atom that is ligated to
the C1 carboxylate O atoms of (R)-homocitrate (Figure 5A). However, the two
13

halves of FeMo-co are joined by three μ2 S atoms that bridge a pair of the six
core Fe atoms. Interestingly, the high-resolution (1.16 Å) crystal structure of the
Mo-nitrogenase complex revealed the presence of a previously unknown
interstitial atom within the core of FeMo-co, hypothesized to be C, N or O at that
time (22). Recently, XES analysis of MoFe-protein has led to the identification of
the interstitial atom as C4- (23), thus confirming FeMo-co to be Fe7S9MoC-(R)homocitrate. The alternative V- and Fe-only-nitrogenases contain similar active
site clusters, called FeV-co and FeFe-co respectively, that are biosynthesized
from orthologues of nif derived proteins (24,25).
Isolated FeMo-co retains no activity which indicates that the amino acid
environment around FeMo-co is important for substrate reduction. Assays to
quantify reduction of either N2 or acetylene as a substrate in the presence of one
another indicated that acetylene is a noncompetitive inhibitor for N2, while N2 is a
competitive inhibitor for acetylene. This was interpreted to mean that there may
be distinct substrate binding sites on FeMo-co (26). To elucidate the amino acid
interactions around and identity of the FeMo-co substrate binding sites, random
MoFe-protein mutations were performed and strains containing these mutations
were set to grow diazotrophically in the presence of acetylene. Diazotrophic
growth of mutant strains in the presence of acetylene would indicate that the
mutation corrects for acetylene inhibition and that the mutant residue position is
pertinent to substrate binding. In this manner, Gly69 was determined to be a key
position as the α-subunit G69S MoFe-protein variant prevented acetylene
binding. Crystal structures of MoFe-protein depicted a Val70 residue, adjacent to
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Gly69, that sits above a 4-Fe face of FeMo-co where the substituted Ser possibly
interacted to prevent acetylene binding (27). Binding of acetylene to FeMo-co
was observed by EPR analysis of MoFe-protein after incubation with Fe-protein.
However, another MoFe-protein variant, α-subunit ΔArg96, was shown to
produce a change in the EPR signal without the need for incubation with Feprotein. Crystal structure analysis placed the Arg96 residue next to Val70 above
the top of FeMo-co, thus further supporting the idea of the 4-Fe face of FeMo-co
being the substrate binding surface (28).

Figure 5 : Structure of the MoFe-protein Metal Clusters
Shown are (A) the active site metal cluster, FeMo-co, consisting of Fe7S9MoC-(R)-homocitrate,
and (B) the electron relay cluster, P-cluster, consisting of Fe8S7. Atoms color coded as green for
Fe, yellow for S, grey for C, red for O, and purple for Mo

Metal Cluster Oxidation States
Similar to the Fe-protein, the MoFe-protein stores, transfers and utilizes
potential energy in the form of reductive electrons. Thus, understanding the metal
cluster oxidation states and midpoint reduction potentials is important. However,
characterization of FeMo-co and P-cluster oxidation states is more complicated
than the Fe-protein Fe4S4 cluster, because of the complexity and dual presence
of the MoFe-protein clusters.
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Multiple oxidations can be observed for P-cluster, though the exact
number of Fe2+ and Fe3+ atoms is not known. The purified wild type MoFe-protein
P-cluster oxidation state is referred to as PN and characterized to be spin silent
and diamagnetic by EPR analysis. Oxidation of P-cluster with thionine results in
three other states, P1+ through P3+, that were distinguished by EPR analysis. The
P1+ and P3+ oxidation states display mixed spin states of S = 1/2 or 5/2, for
P1+(29), and S = 1/2 and 7/2, for P3+. The P2+ oxidation state displays an integer
spin, presumably S = 3, that can be characterized with parallel mode EPR (30).
These results have led to the suggestion of each half of the P-cluster being
oxidized separately to yield mixed spin states on odd oxidations and diamagnetic
or integer spin states on even oxidations. The P1+/N, P2+/1+ and P3+/2+ redox
couples are measured to be -310, -310 and +90 mV, respectively, by EPR
monitored redox titrations (29,31,32), but the redox couple pertinent to the Pcluster electron relay function is unknown and may even consist of a
combination. Of the three redox couples, the P2+/1+ redox couple midpoint
potential was shown to be pH dependent, ranging from -224 mV at pH 6.0 to 348 mV at pH 8.5 (33).
EPR characterization of purified MoFe-protein reveals an S = 3/2 spin
state with g values of 4.3, 3.7 and 2.01 that is assigned to the as-purified FeMoco state, MN, because PN is diamagnetic (34). The exact oxidation state of FeMoco, like P-cluster, is not known and so the purified state is referred to the MN
state. Oxidation of MN to MOx with thionine results in a diamagnetic cluster.
Controlled potential coulometry with thionine placed the midpoint potential of the
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MOx/N redox couple at -40 mV (35-37). Mössbauer characterization of MoFeprotein implies that there exists a reduced MR state during N2 reduction activity
with a calculated integer spin number that is greater than or equal to 1, although
no midpoint potential for the MN/R redox has been measured directly. Recent
characterization of a trapped hydride bound FeMo-co intermediate led to the
suggestion that FeMo-co only cycles through one redox couple (38,39). This and
other intermediates, mentioned below, provide insight on how the energy stored
in the clusters may be put towards a mechanism of reducing substrates.
A “Draft Mechanism” for Reduction of N2
Though the exact electron pathway is not absolutely known, the general
consensus is that an electron from the Fe-protein cluster is passed to P-cluster
and relayed to FeMo-co. This is feasible considering the suitable midpoint
potentials for the [Fe4S4]2+/1+, at -420 mV, and the PN/1+ or P1+/2+ , at 309 mV. The
requirement for protons in the substrate reduction catalyzed by FeMo-co implies
that there must exist some means by which protons are directed to the active
site. A possible route for protons to follow is evident in redox dependent
conformational changes around the P-cluster that are observed through crystal
structure analysis of the P-cluster in two different oxidation states. The crystal
structures point out reversible ligation of the β-subunit Ser188 O atom and αsubunit Cys88 peptide backbone N atom to the P-cluster as a feature of redox
dependent conformational changes (40). The pH dependence of the P2+/1+ redox
couple, in conjunction with the possible redox dependent deprotonation sites,
support the idea of a proton coupled electron transfer (PCET). Under such a
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model, FeMo-co accumulates an electron relayed from the P-cluster along with a
proton during each cycle of Fe-protein turnover. In the Thorneley-Lowe kinetic
model, each intermediate state of FeMo-co is the result of e- and H+ transfer
associated with Fe-protein turnover and can be denoted as EN, where N is the
number of Fe-protein turnovers. After E8, N2 and 2H+ are reduced to 2NH3 and
H2. Recent characterizations of freeze trapped MoFe-protein in mid-turnover
through 2H and 57Fe Electron Nuclear DOuble Resonance (ENDOR), Electron
Spin Echo Envelope Modulation (ESEEM), and HYperfine Sublevel COrRElation
(HYSCORE) spectroscopies have identified dual hydride bound, NH2 bound, and
NH3 bound FeMo-co intermediates that are representative of the E4, E7, and E8
states (41) and led to the proposal of a draft mechanism (Figure 6). The E4
intermediate, called the Janus intermediate, evidences the storage of four
electrons in two metal-hydride-metal bridges while two protons are placed on the
adjacent S atoms. The Janus intermediate is understood to evolve the obligate
H2 molecule upon binding of N2. The initial steps of electron and proton
accumulation on FeMo-co for N2 reduction thus consist of: one metal-hydridemetal formation and sulfur protonation (Figure 6 E0 - E2), second metal-hydridemetal formation and sulfur protonation (Figure 6 E2 – E4), and simultaneous
binding of N2 and evolution of H2 (Figure 6 E4). Two separate reduction paths
may be possible at this point: 1) Each nitrogen atom is reduced in parallel to yield
diazine, hydrazido, hydrazine and amido intermediates respectively (Figure 6 E4
– E7), or 2) the nitrogen atoms are reduced in series to yield diazido, nitrido,
imido and amido intermediates (Figure 6 E4 – E7). The amido bound intermediate
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(Figure 6 E7) is reduced to ammonia (Figure 6 E8) and subsequently released to
restart the cycle.

Figure 6 : Draft Mechanism of Nitrogenase Function
Each Fe-protein turnover associated reduction step is highlighted in purple and labeled EN, where
N is the number of turnovers. Splits in the mechanism are proposed at the E4 through E6 steps.
Depending on the way N2 binds the cluster at E4, focused or simultaneous N atom reduction may
occur. Additional reductions at E5 and E6 may also proceed by focusing on a single N atom or
alternating between both N atoms.

Further characterization of the Mo-nitrogenase substrate reduction reaction
mechanism will require elucidation of more intermediates and developments in
understanding of FeMo-co and P-cluster oxidation states and electron pathways.
Unknowns of the Mo-nitrogenase Complex
While recent developments have yielded a better understanding of the
Mo-nitrogenase mechanism, a full mechanism is still not available. This requires
both a better understanding of the oxidation states of the MoFe-protein clusters
and identification of the more key intermediates. Additionally, both the synthesis
of P-cluster and FeMo-co are not completely understood.
The P1 through P3+ states are all referenced to the as-purified P-cluster
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state, dubbed PN. The exact Fe2+ and Fe3+ composition, and thus exact charge,
of P-cluster has not been identified. The same can be said for the MN and MR
FeMo-co oxidation states. Characterization of the Fe2+ and Fe3+ identity of each
Fe atom within the cluster is difficult due to the total number of Fe atoms present
and because of the delocalized nature of clusters in the absence of substrates.
Mössbauer and Fe K-edge EXAFS characterization of MoFe-protein can only
provide Fe2+ and Fe3+ ratios but the contribution of each cluster cannot be
distinguished. Characterization of Fe2+ and Fe3+ composition of isolated clusters
may be possible but would not identify the oxidation state pertinent for Monitrogenase activity. Identification of oxidation states may provide insight towards
understanding how the electron from Fe-protein are passed to FeMo-co and
substrates. Multiple redox couples have been identified for the P-cluster but it is
unknown whether a specific or multiple redox couple(s) play a role in passing the
electrons from Fe-protein to FeMo-co. An understanding of the redox couples
and identification of an electron path through peptide environment between the
clusters is challenging because there is no way to “label” an electron.
Biosynthesis of the FeMo-co
The biosynthesis of FeMo-co and the structure and composition of the
FeMo-co precursors, NifB-cofactor (NifB-co) and L-cluster, remains enigmatic.
The synthesis of FeMo-co has never been achieved by chemical methods (42),
and biochemical synthesis of FeMo-co requires the combined functions of eight
Nif proteins (Figure 7A); NifS, NifU, NifB, NifX, NifEN, NifV, Fe-protein and NafY.
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Figure 7 : Putative Mo-nitrogenase Biosynthetic Pathway
Shown in (A) with a light green backdrop is the FeMo-co biosynthetic pathway. Here, the
combined functions of seven enzymes produce the Mo-nitrogenase active site metal cluster. The
apo-MoFe-protein maturation pathway is highlighted in (B) with a blue backdrop. This pathway
consists of P-cluster formation and FeMo-co insertion to produce active MoFe-protein.

In order to design new generation catalysts based off FeMo-co for industrial
nitrogen fixation, an appreciation and full understanding of FeMo-co biosynthesis
is likely to be beneficial. This section will present what is known about the FeMoco biosynthetic pathway in three parts separated as early, intermediate and late
cluster synthesis.
Early Cluster Synthesis
Fe-S clusters in proteins generally function to store or transfer electrons.
The Fe4S4 clusters of Fe-protein and NifEN are understood to follow this general
function within the nitrogenase biosynthetic pathway (43,44). Alternatively, the
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Fe4S4 clusters of the NifB enzyme and immature MoFe-protein are thought to
function as base clusters that are processed to become NifB-co and P-cluster,
respectively (45,46). The versatile nature of small Fe-S clusters within the
nitrogenase biosynthetic pathway merits the understanding of where and how
they are constructed. Biosynthesis of small clusters in the Mo-nitrogenase
biosynthetic pathway is proposed to be catalyzed by the join activities of NifS, a
PLP dependent cysteine desulferase, and the Fe-S cluster scaffold protein, NifU.
Genetic Analysis of nifS and nifU
In past studies, the function of the nifS and nifU gene products was linked
with the activity of Fe-protein. Changes in the activity of a Fe-protein upon
introduction of specific gene deletions would indicate that the deleted gene is
associated with Fe-protein in some way. These studies determined the activity of
Fe-protein through quantification of ethylene formed from acetylene reduction
assays containing crude extracts of A. vinelandii strains supplied with an excess
of purified MoFe-protein. The ΔnifS and ΔnifU single deletions, DJ105 and
DJ116, displayed an approximate 15-fold decrease in Fe-protein activity
compared to wildtype, while the ΔnifSU double deletion, DJ262, displayed an
approximated 100-fold decrease (47,48). These results showed the significance
of the nifS and nifU gene products in the Fe-protein function, likely due to the
NifS and NifU enzymes being the source of the Fe4S4 cluster.
In a similar manner, complementation studies between crude extracts of
the ΔnifB A. vinelandii strain, UW45, and the ΔnifN mutant Klebsiella
pneumoniae strain, UN1217, have associated the nifS and nifU gene product
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activity with NifB. The ΔnifN mutation in UN1217 prevents FeMo-co biosynthesis
and instead resulted in accumulation of the NifB Fe-S cluster product, NifB-co.
Both UW45 and UN1217 exhibit Nif(-) phenotypes separately, but are able to
synthesize an active Mo-nitrogenase complex upon mixing of lysis extracts in
vitro. Using this experimental system, the hypothesis that NifS and NifU support
FeMo-co biosynthesis was tested. Either nifS, nifU, or both nifS and nifU were
deleted by chromosomal recombinant methods in UN1217. Complementation of
UW45 extracts with the extracts from UN1217 derived mutants with deleted nifU,
NifS or both was able to mature nitrogenase, indicating that the implied cluster
synthesis function of nifS and nifU gene products is associated with the function
of NifB (45). This result indicated that the NifS and NifU enzymes are the source
of Fe2S2 or Fe4S4 clusters delivered to NifB and possibly other Nif proteins.
Structure and Function of NifU
NifU is an Fe-S cluster scaffold protein homodimer that contains a stable
two Fe2S2 clusters bound by Cys137, Cys139, Cys172 and Cys175 in each
subunit (49). Site directed mutagenesis of the nine cysteine residues to alanine in
the A. vinelandii NifU peptide sequence indicates that, in addition to the cysteine
residues mentioned before, Cys35, Cys62 and Cys106 are also required for full
in vivo functionality as determined by monitoring diazotrophic growth rates (50).
Analysis of an N-terminally truncated variant of NifU (NifU-1), lacking the cysteine
residues that bind the stable Fe2S2 cluster, by low temperature Resonance
Raman (RR) revealed the presence of a 314 and 368 cm-1 band that is
characteristic of a rubredoxin-like tetrahedral ferric center. By chance, site
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directed mutagenesis of the NifU-1 Asp37 to Ala resulted in the discovery of a
second, transient, Fe2S2 cluster. The assembly of clusters on wildtype and
variant NifU can be observed with the addition of ferric ammonium citrate, βmercaptoethanol, L-cysteine and NifS. This indicated that NifS is able to direct
cluster assembly on NifU by providing the required sulfide ions, however no copurification or co-detection of NifS was observed in NifU purifications by western
blots. Interestingly, addition of strong reducing agents, such as dithionite, to NifU
samples resulted in the complete disappearance of the Fe2S2 characteristic
signals from UV and RR spectroscopies. This absence was accompanied by the
lack of paramagnetic or chiral species that could be examined by EPR or circular
dichroism (51). It may be possible that the small Fe2S2 clusters are fused to form
a [Fe4S4]2+ cluster, and that the function of NifU is to both facilitate Fe2S2
formation and reductive synthesis of Fe4S4 clusters.
Intermediate Cluster Synthesis
Synthesis of complex precursors of FeMo-co from small clusters is
attributed to the NifB enzyme. Bioinformatics analysis of the NifB polypeptide
reveals an N-terminal CxxxCxxC sequence, known to bind Fe4S4 clusters, and a
glycine rich sequence that is reminiscent of S-adenosylmethionine (SAM) binding
sites in methyltransferases (Figure 8).
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Figure 8 : Sequence Alignment of Selected Radical SAM Superfamily Members
Shown are the peptide sequences of well-known members of the radical SAM superfamily of
enzymes. Each peptide is preceded and followed by the residue position within the respective
enzyme listed at the very right. The conserved cysteines in the CxxxCxxC motif are displayed in
red. Depicted below the sequence alignment is a Fe4S4 cluster in the 2+ oxidation state bound to
the conserved cysteines and a SAM molecule. Atoms are depicted in brown for Fe, yellow for S,
dark blue for N, red for O, grey for C and light blue for H.

These distinguishing features characterize NifB as a member of the radical SAM
superfamily of enzymes (52). Members of this enzyme superfamily include
pyruvate formate lyase activating enzyme, lysine amino mutase, and biotin
synthase. Members of this family range in function widely and so it is difficult to
assign a function to any one enzyme. For example, the members mentioned
above act as a glycyl radical generator, an isomerase, and sulfur insertase,
respectively. However, the common feature in this superfamily of enzymes is the
ability to ligate and utilize a Fe4S4 cluster to generate a radical on SAM. The SAM
radical is then directed in a very controlled manner by the peptide environment to
perform a variety of chemical reactions
25

Genetics and Limited Characterization of NifB
Interestingly, there is no nifB analogue in the A. vinelandii vnf and anf
nitrogenase biosynthetic pathways that produce the V- and Fe-only nitrogenases,
respectively (24,25). Deletion of nifB in A. vinelandii resulted in the inability for
diazotrophic growth regardless of the availability of Mo, V and Fe, suggesting
that nifB is an essential gene in all three nitrogenase biosynthetic pathways (53).
The idea of a shared NifB enzyme is supported by the location of the nifB gene
being in a separate cistron from that of the Mo-nitrogenase biosynthesis genes,
nifHDKENXUSV (Figure 9).

Figure 9 : Simplified Depiction of the nif Gene Cluster
The nif gene cluster is under the control of proteins sensitive to the levels of fixed nitrogen, NifA
and NifL. Interestingly, nifB is located on the same cistron as nifL and nifA, and is thus not under
regulate in conjunction with the genes of the Mo-nitrogenase biosynthetic pathway.

Thus, nifB is not under the same expression regulation by nifL and nifA as the
Mo-nitrogenase biosynthesis genes, and could therefore be expressed
separately to function in V- and Fe-only nitrogenase biosynthesis (24).
In the past, poly-His tagged NifB has been purified with the use of a costly
detergent (n-dodecyl-β-D-maltopyranoside). However, the poly-His tagged NifB
was purified in low yield (20 mg/kg cells paste) in addition to being weakly active,
thus rendering the technique unfeasible for long term enzymological studies (54).
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An active NifB fused to NifEN (NifEN-NifB) has been purified but the requirement
of NifEN co-purification prevents true isolation and characterization of NifB and
NifB-co. However, these limited purifications have brought forth what little
characterization exists for NifB.
Unlike most of the radical SAM enzymes, NifB was shown to be a dimer
by analytical gel filtration. Quantitative analysis for Fe indicates the presence of
more than four Fe atoms within each subunit. EPR characterization of NifEN-NifB
reveals an S = 1/2 signal with g values of 2.02, 1.95 and 1.94 characteristic of
Fe4S4 clusters. Integration of the S = 1/2 EPR signal indicates that there can be
two, or more, Fe4S4 clusters within NifB that is fused to NifEN (54,55). Earlier
attempts to purify NifB were made, but instead yielded the low molecular-weight
complex of NifB-co, a biochemical product of NifB. Complementation of UW45
extracts with NifB-co resulted in activation of the Mo-nitrogenase complex,
implying that NifB-co may be a precursor to FeMo-co (56). Subsequent studies of
the same complementation reaction with UW45 were performed using NifB-co
containing 35S and 55Fe. These radiolabel studies detected that the MoFeprotein, matured using 35S or 55Fe NifB-co, contained the radiolabel, thus
confirming that NifB-co is a precursor to FeMo-co (57). NifB was later confirmed
to likely form NifB-co as a precursor of FeMo-co by demonstrating that NifB-co
can be replaced with NifB, Fe2+, S2- and SAM to produce an active Monitrogenase complex in vitro reactions (58).
After the identification of the central carbon atom, the source of the central
carbon was brought into question. Recently, utilization of radioisotopically
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modified SAM with NifEN-NifB has linked the carbon of the methyl group of SAM
to become the central carbon within FeMo-co. Liquid chromatography mass
spectrometry analysis of the SAM byproducts of NifB catalysis revealed the
presence of S-adenosylhomocysteine and 5’-deoxyadenosine (5’-dAH), which
suggests that the methyl group is absent. When NifEN-NifB is incubated with
SAM that contains a deuterated methyl functional group, a mixture of 5’-dAH and
5’-daD is observed. The presence of 5’-dAD could be due to radical abstraction
of a proton by the generated 5-dA* radical from the deuterated methyl functional
group during catalysis. To track the carbon movement, 14C-SAM was used with
NifEN-NifB either separately or in conjunction with Fe-protein and apo-MoFeprotein. Use of both poly-His tagged and normal protein, for immobilized metal
affinity chromatography, and extensive washing, to remove excess 14C-SAM,
indicated that the radiolabel can be found within NifEN-NifB and later in MoFeprotein. Extraction of FeMo-co from MoFe-protein and the precursors from
NifEN-NifB indicated the presence of a radiolabel within the clusters. Movement
of the 14C atom from SAM into the clusters thus suggested a carbon insertion
function for NifB (59).
NifB Cofactor Product, NifB-co
NifB-co has a dark greenish-brown color that quickly fades upon exposure
to air. Sensitivity to oxidation by O2 is apparent by the less than 15 second half
life of NifB-co in open air (56). This extreme oxidative sensitivity, coupled with the
transient existence of NifB-co between NifB catalysis and NifEN processing, has
proven to be a challenging obstacle in characterizing NifB-co structure and
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composition. Standard structural characterization of NifB-co by X-ray
crystallographic analysis has not been possible due to the inability to crystallize
proteins known to bind NifB-co and the presence of detergent, N-dodecyldimethyl-3-ammonio-1-propane-sulfonate (SB12), in NifB-co preparations. NifBco is diamagnetic in nature and is not EPR active, and thus cannot be studied by
advanced magnetic resonance techniques such as ENDOR and ESEEM (56).
Therefore, structural characterization of NifB-co has solely relied on EXAFS and
NRVS techniques. Fe K-edge EXAFS and 57Fe NRVS characterization of NifB-co
bound to NifX, described in the next section, suggest that NifB-co is Fe6S9C
cluster (Figure 10).

Figure 10 : Possible Structures of NifB-co
Depicted are the 6-, 7- and 8-Fe structural models of NifB-co. The 6-Fe structure resembles the
“core” of FeMo-co, where addition of one or two terminal Fe atoms produces the 7- and 8-Fe
models. Atoms are colored green for Fe, yellow for S, and grey for C.

The combined knowledge that the nifB gene is located on a separate
cistron from that of the Mo-nitrogenase biosynthesis genes, that the nifB gene is
essential for all three nitrogenase systems, and that the NifB enzyme functions to
synthesize NifB-co suggests that the activity and cluster product of NifB is a
common step in all three nitrogenase biosynthetic pathways. A shared precursor
cluster scheme for nitrogenase biosynthesis would indicate that NifB-co is
differentially processed (Figure 11c, e-f) depending on the availability of specific
metal atoms, Mo, V or Fe only, to produce FeMo-co, FeV-co or FeFe-co in order
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to viably activate any nitrogenase to survive fixed nitrogen deficient conditions.

Figure 11 : Nitrogenase Active Site Metal Cluster Biosynthesis.
The biosynthesis is understood to enzymatically process from (a) small ions to Fe2S2 and Fe4S4
clusters, then to (b) NifB-co, (c) L-cluster, and finally (d) FeMo-co. There is some evidence to
suggest that NifB-co may also be used by the (e) vnf nitrogenase and (f) anf nitrogenase
systems.

Characterization of NifB-co Bound NifX
NifX is an 18 kDa monomer that is easily purifiable, stable in the presence
of air and has been shown to accumulate 55Fe upon interaction with 55Fe NifB-co
(60,61). NifX was determined not to be essential in the Mo-nitrogenase
biosynthetic pathway because the ΔnifX genotype in A. vinelandii does not
produce a Nif(-) phenotype. However, experiments with in vitro FeMo-co
biosynthesis reactions showed that the addition of NifX to reaction mixtures
containing apo-MoFe-protein, Fe-protein, NifEN, NifB-co and ΔnifENX A.
vinelandii extract increases FeMo-co synthesis 15-fold (62). N-terminal
sequencing identified NifX as the protein that accumulated an 55Fe label in
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assays that complement ΔnifDKΔnifB::kanR mutant A. vinelandii, Ca117.3, with
55

Fe NifB-co, thus implying that NifX may bind NifB-co. NifX was evidenced to

bind NifB-co by monitoring saturation of the changes in the NifX circular
dichroism spectra upon titration of NifB-co, with a Kd calculated to be 1 - 4 μM.
NifX was observed to act as a NifB-co chaperone protein by Fe stained anoxic
native gels that demonstrated an increase in Fe within NifEN upon the addition of
NifB-co bound NifX.
The ability to produce NifB-co bound NifX provided the opportunity to
perform comparative Fe K-edge EXAFS characterization of NifX bound NifB-co
and FeMo-co bound to the NifX-like chaperone protein, NafY. For the analysis of
the EXAFS data, models for NifB-co were made with complexes having 6-, 7- , or
8-Fe structures. The 6-Fe NifB-co structure resembles the FeMo-co “core” that
can be described as a trigonal prism of D3h symmetry, where additional ligation of
one or two terminal Fe atoms results in the 7-Fe or 8-Fe structures. The
distances and mean square deviations of the distances, or Debye-Waller factors,
of each Fe interaction within the three NifB-co models were optimized with a
least squares fitting algorithm to best fit the collected data. EXAFS analysis
reveals that the 6-Fe model best fits the data collected on the NifX bound NifBco, though the 7-Fe and 8-Fe models are also reasonable. To investigate the
possible presence of the central atom in NifB-co, multidimensional search
profiles were performed to determine a possible coordination number and
distance for the Fe to central atom interaction. The results indicated that the
presence of one central atom, that is 2.06 Å from the 6 core Fe atoms,
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significantly contributes to and drastically improves the fitting of the EXAFS data.
Partial vibrational density of states (PVDOS) for the NifB-co models are then
derived and used to fit nuclear resonance vibrational spectroscopy (NRVS) data
collected for NifX bound NifB-co to compare with both FeMo-co and NafY bound
FeMo-co.
NRVS was used to derive a partial vibrational density of states (PVDOS)
for NifX bound NifB-co and compare to that of both FeMo-co and NafY bound
FeMo-co. NifB-co was shown to have Fe-S stretching and bending modes similar
to isolated FeMo-co. Central carbon presence in NifB-co was corroborated by a
feature in the NifB-co PVDOS consisting of a 185 – 200 cm-1 signal characteristic
to vibrational modes assigned to the center carbon in FeMo-co (63). Together,
the NRVS/EXAFS data and NifB carbon insertase characterization suggest that
NifB-co is a Fe6S9C cluster.
Late Cluster Synthesis
Maturation of the intermediate stage precursor cluster, NifB-co, to FeMoco at the NifEN step depends on the availability of Mo, (R)-homocitrate, and of
electrons from Fe-protein (43,64). FeMo-co synthesis has been shown to
minimally require NifB-co, MoO42-, (R)-homocitrate, NifEN, MgATP and Feprotein. However, the mechanisms for late stage process of NifB-co maturation
by NifEN and Fe-protein is as enigmatic as the biosynthesis of NifB-co by NifB.
The lack of understanding for the events in NifB-co maturation portrays NifEN as
a “blackbox” within which the incorporation of Mo, (R)-homocitrate, and possibly
more Fe or S into NifB-co is catalyzed.
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Structure and Characterization of NifEN and Bound Clusters
Similar to the MoFe-protein, NifEN is the heterotetramer product of the
proteins coded by nifE, α-subunit, and nifN, β-subunit (65). EPR analysis of
NifEN purified from DJ1041, a Nif(-) phenotype A. vinelandii strain that contains a
poly-His::nifE mutation, revealed an S = 1/2 signal with g values of 2.10, 1.92 and
1.85 that is characteristic of complex Fe-S clusters. Combined EPR, UV-visible,
circular dichroism and resonance Raman spectroscopies reveal the presence of
two Fe4S4 clusters per heterotetramer of NifEN. (66). EPR monitored redox
titration of the Fe4S4 cluster calculates a midpoint potential of -350 mV for the
[Fe4S4]2+/1+ redox couple. A second cluster, now called the L-cluster, was
distinguished from the Fe4S4 by EPR analysis of NifEN purified from various
mutant strains. To distinguish the signal contribution from Fe4S4 clusters, a
DJ1041 mutant was constructed to contain a kanR insertion within nifB. Under
the assumption that a processed form of NifB-co is present in NifEN, the ΔnifB
derivatized DJ1041 strain is then unable to synthesize NifB-co and thus NifEN is
left to contain only Fe4S4 clusters. Comparison of EPR spectra indicated that the
S = 1/2 signal from apo-NifEN is not rhombic like that of holo-NifEN and that only
the S = 1/2 signal from holo-NifEN is temperature dependent. Spin integration
indicated that the holo-NifEN has twice as many Fe-S clusters than apo-NifEN,
which was interpreted to mean that the signal was derived from a second cluster
composed of 8 Fe atoms (twice that of Fe4S4) (67).
2.6 Å resolution X-ray crystallography was performed on NifEN samples
from ΔnifB DJ1041, DJ1041 and post reaction NifEN with bound FeMo-co. The
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crystal structure analysis confirmed the presence of a Fe4S4 between each αand β-subunit interface, a position analogous to that of P-cluster in MoFe. The
Fe4S4 clusters are ligated by Cys44 of the β-subunit and Cys37, Cys62, and
Cys124 of the α-subunit and Cys. Crystal structure analysis also revealed the
presence of a larger cluster within the NifE subunit, a position analogous to that
of FeMo-co in MoFe-protein. The exact structure of the cluster is difficult to
interpret because the atoms cannot be resolved at 2.6 Å. This cluster, named the
L-cluster by the authors, contains only Fe and S, and is similar to FeMo-co (68).
Activation of apo-MoFe-protein by holo-NifEN in FeMo-co maturation assays has
identified L-cluster as a FeMo-co precursor (67,68). Isolation of the L-cluster from
NifEN has also been possible by acid treatment followed by extraction with Nmethylformamide, a procedure that has been optimized to isolate FeMo-co from
MoFe-protein. Fe K-edge EXAFS was performed on the isolated L-cluster in
similar in manner to that of the NifB-co EXAFS experiment. 7-Fe and 8-Fe
models of the L-cluster were used to fit the collected EXAFS data, with 8-Fe
providing the best fit and corroborating the possibility that L-cluster is an 8-Fe
precursor of FeMo-co (Figure 10, 8-Fe) (69).
Experiments with apo-NifEN derived from the ΔnifB A. vinelandii strain,
UW243, and NifX bound NifB-co showed that NifB-co is transferred to NifEN.
Likewise, holo-NifEN was also shown to transfer Fe-S clusters to unbound NifX
by diaminobenzoic acid Fe staining of agarose gels. NifX bound to the cluster
extracted from NifEN, was shown to be able to complement UW45 extracts in
FeMo-co synthesis, suggesting that the extracted cluster from NifEN is also a
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FeMo-co precursor. The NifX extracted cluster from NifEN, called the VK-cluster,
exhibited an S = 1/2 spin state by EPR analysis and could be reversibly oxidized
by thionine and reduced back with dithionite. These results distinguished the VKcluster from spin silent NifB-co, and thus the VK-cluster and L-cluster may be the
same (61).
Maturation of FeMo-co Precursors by NifEN
Presence of the Mo in the FeMo-co structure warrants the question of
where it is derived from. Past experiments have indicated that

99

Mo accumulates

within NifEN, NifH and NifX when provided with MgATP and reducing agents
(70). Of the three 99Mo binding proteins, only NifEN is a likely a scaffold for
precursor synthesis or processing. To investigate the association of Mo with
NifEN, experiments were performed to compare the extent to which holo-NifEN
can complement UW45 extracts without NifB-co in limiting and excess MoO42conditions. No difference in complementation was observed between the limiting
and excess Mo sets. After inductively coupled plasma atomic emission
spectroscopy revealed that virtually no Mo was present in the UW45 extract, the
combined results indicated that NifEN is the Mo entry point for FeMo-co
biosynthesis (64).
FeMo-co synthesis also requires that (R)-homocitrate is synthesized and
ligated to a precursor at some point. The A. vinelandii nifV gene was shown to be
strikingly similar to the gene encoding for homocitrate synthase in
Saccharomyces cerevisiae (71). Support for nifV encoding a homocitrate
synthase was evidenced by MoFe-protein from ΔnifV K. pneumoniae that was
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shown to have attenuated activity and observed, by X-ray crystal analysis, to
substitute citrate in the active site cluster position where homocitrate would be
found (72). Homocitrate synthase activity of NifV was confirmed by gas
chromatography mass spectroscopy in reaction mixtures containing acetyl-CoA
and various ketones. Acetyl-CoA was determined to most likely condense with αketoglutarate through stereospecific carboxylation at the 2-oxo position to yield
(R)-homocitrate and CoA-SH. This is similar to the S. cerevisiae homocitrate
synthase activity which is known to contain a Zn2+ atom. This Zn2+ atom is likely
not present in NifV as it may act as a poison in the Mo-nitrogenase biosynthetic
system, and could possibly be replaced by another divalent atom.
MgATP dependent Fe-protein function was shown to be necessary for the
insertion of both Mo and (R)-homocitrate into the NifEN based precursor towards
synthesizing FeMo-co. This was evidenced by experiments that repurify NifEN
and Fe-protein after incubation together in the presence of MgATP, MoO42- and
(R)-homocitrate. Complementation of the post incubation NifEN with apoMoFeprotein results in activation as measured by acetylene reduction. However no
activity was observed when apo-MoFe-protein was complemented with post
incubation Fe-protein. Metal analysis of post incubation Fe-protein revealed the
presence of Mo, which was confirmed by Mo K-edge EXAFS. The presence of
Mo is abrogated when MgATP was absent or replaced by MgADP, indicating that
the Mo interaction with Fe-protein is related to the MgATP hydrolysis function.
Considering the MgATP dependent turnover cycle for electron transfer from Feprotein to MoFe-protein and the similarities of MoFe-protein and NifEN, it is
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tempting to think that Fe-protein docking onto NifEN results in the reduction of
Mo(VI) from MoO42- to Mo(V) or Mo(IV). In any case, these results indicate that
Fe-protein turnover in the NifEN complex somehow activates the incorporation of
Mo and (R)-homocitrate into the precursor cluster to produce FeMo-co.
Important Unknowns of the FeMo-co Biosynthetic Pathway
NifB and NifB-co
Personal communication and anecdotal data brand NifB as a challenging
enzyme to purify. For this reason, characterization of NifB has been very limited.
The recent advancements in NifB enzymology are due to a NifEN fused form of
NifB, but this NifEN-NifB fused interaction is still another larger “blackbox”. Use of
the Fe4S4 within NifB to produce FeMo-co precursors has been proposed to be a
radically directed reaction through the use of NifEN-NifB and labeled SAM.
Elucidation of the mechanism for NifB precursor synthesis requires trapped
intermediates to be examined. This is made difficult by the presence of NifEN
around NifB (59). The understanding of cluster synthesis catalyzed by NifB is still
in its infancy. Do both Fe4S4 clusters of NifB become incorporated into a FeMoco precursor? How many reduction equivalents and SAM molecules are
necessary for the synthesis of a single precursor? What is the physiological
reducing agent for NifB? How do the clusters get regenerated or replaced if they
are incorporated into a precursor? To answer these questions, a readily purifiable
and unadulterated form of NifB is necessary.
Recent characterization of NifEN-NifB with 14C-SAM identified the carbon
insertion function of NifB and tracked the carbon within the L-cluster and FeMo-
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co. NifB-co is a direct product of NifB and is thus likely to be the first FeMo-co
precursor to contain the central carbon. The possibility of NifB-co containing a
central carbon was already suggested by Fe K-edge EXAFS and 57Fe NRVS
analysis but the fused nature of NifEN-NifB prevents the isolation of NifB-co for
detection of a radiolabel transfer from

14

C-SAM. Additionally, the structure and

composition of NifB-co is still topic for debate and determination of a 6-, 7-, or 8Fe structure for NifB-co will require new means to manipulate NifB-co towards
characterization. X-ray crystallography of enzyme bound NifB-co would be ideal
in determining structure and composition. While a NifEN-NifB crystal may be
possible, NifB-co likely would not be found on the crystal because of immediate
processing by NifEN. Therefore, this will require a crystal of NifB-co bound NifX
or, again, a readily purifiable and unadulterated form of NifB for crystallization.
NifEN “Blackbox”
One of the biggest mysteries of nitrogenase biosynthesis involves the
exact events within the NifEN “blackbox”. NifEN was indicated in the
incorporation of at least Mo and (R)-homocitrate, if not also more Fe or S, into
NifB-co to produce FeMo-co but the exact process and order is poorly
understood. If L-cluster is composed 8-Fe atoms then one terminal Fe atom must
be replaced by Mo or Mo bound to (R)-homocitrate in order to yield FeMo-co.
This same could be said for an L-cluster composed of 7-Fe atoms without the
need for a terminal Fe removal. Delivery of (R)-homocitrate, presumably from
NifV, is largely unexplored but must occur some way in conjunction with Mo
delivery or processing. Mo accumulation in both Fe-protein and NifEN suggests
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that Fe-protein may have some role in the insertion of Mo, and possibly (R)homocitrate, into the precursor cluster. This is supported by the observation that
MoO42- contains Mo(VI) while Mo K-edge EXAFS indicate Mo(IV) in FeMoco(73). However, the function of the electrons, the path of electron flow and the
delivery of Mo and (R)-homocitrate requires more investigation.
Like NifB-co, the exact structure of L-cluster has not been irrefutably
confirmed. NifB-co, L-cluster and FeMo-co are thought to be composed of the
same “core” and only vary in the presence of Fe or Mo at the terminal ends. To
assign a strict structure and composition, specific identification of terminal Fe
atoms in L-cluster is necessary. The 8-Fe model of L-cluster was proposed from
EXAFS determinations, but these studies do not include long distance terminal
Fe to core Fe interactions during fitting. In addition, the crystal structure of NifEN
cannot resolve electron densities from terminal Fe atoms at 2.6 Å resolution and
therefore cannot clearly identify the structure and composition of L-cluster.
Contents of this Dissertation
The focus of this dissertation will be on the characterization of the NifB
enzyme and NifB cofactor. For this aim, Chapter 2 will describe the construction
and purification of glutathione-S-transferase (GST) fused NifB expressed from an
A. vinelandii strain that does not contain NifEN, Fe-protein, MoFe-protein, or
NifX. This expression system will be used to isolate NifB in order to perform
biochemical characterization of the NifB enzyme activities. Chapter 3 will
describe a spectroscopic characterization of NifB-co samples in the presence of
selenol-modified ligands. This experiment expands on previous Fe K-edge
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EXAFS studies performed on NifB-co to further characterize the structure,
composition and ligand binding sites on NifB-co. Finally, Chapter 4 will
summarize the works of this dissertation in the context of FeMo-co biosynthesis
and conclude with some of the remaining unknowns of the Mo-nitrogenase field
of study.
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CHAPTER 2: ISOLATION OF GST-NIFB
Abstract
NifB is an essential enzyme within the FeMo-co biosynthetic pathway that
has been shown to synthesize the FeMo-co precursor, NifB-co. During the
synthesis of NifB-co, NifB performs a key task of inserting a carbon atom, derived
from the methyl carbon of SAM, which becomes the central carbon of FeMo-co.
Characterization and understanding of NifB has been slow to develop due to the
challenges associated with NifB isolation and the limitations of current purification
methods. Presented here is the development of an A. vinelandii strain, CF002,
that has been engineered to contain a fused GST-nifB downstream and under
the control of the nif promoter, which would allow rapid affinity based purification
of the expressed GST-NifB protein. Western blot analysis of expression tests
indicate that upon derepression, a product of appropriate molecular weight
containing GST is produced. Biochemical assays indicate that the lysis extract of
CF002 is able to complement UW45 and yield an active Mo-nitrogenase
complex. The CF002 extract was then used for GST purification to yield isolation
of the protein that is confirmed to be GST-NifB by mass spectroscopic proteome
analysis.
Introduction
The molybdenum nitrogenase complex plays an important role in
biological nitrogen fixation by facilitating the reduction of N2 to NH3. This complex
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consists of two components, the Fe-protein and the MoFe-protein, that utilize the
hydrolysis of MgATP to transfer electrons between three metal clusters. The
MoFe-protein active site metal cluster, FeMo-co, is the final cluster to accept
electrons towards the reduction of N2 and other substrates (1,2). Recent X-ray
Emission Spectroscopy (XES) characterizations of isolated FeMo-co and MoFeprotein bound FeMo-co compared to the ΔnifB MoFe-protein variant allowed for
computational determination of the identity of the atom at the center of FeMo-co.
Of the three possible candidates for the interstitial atom, C, N or O, carbon was
identified as the best fit, thus concluding the composition as a Fe 7S9MoC-(R)homocitrate cluster (3). Synthesis of FeMo-co is only possible biologically
through an enigmatic process that requires the functions of eight enzymes and
proteins; NifS, NifU, NifB, NifX, NifEN, NifV, Fe-protein and NafY (Figure 7A). Of
these eight enzymes and proteins, the activity of NifB, NifEN and Fe-protein
cannot be substituted by the addition of simple chemicals. Of these three
essential enzymes, NifB is the least understood. NifB synthesizes the intial
FeMo-co precursor, NifB-co (4), thought to be a 6-Fe cluster (5). However,
characterization of NifB and NifB-co has been limited due their transient nature
and extreme oxidative sensitivity.
The A. vinelandii NifB enzyme is a 110 kDa homodimer of the nifB gene
product. Sequence analysis confirms the presence of a CxxxCxxC and glycine
rich sequences that categorize NifB as a member of the radical SAM superfamily
of enzymes (6). The enzymes of the radical SAM superfamily catalyze a wide
variety of catalytic functions such as isomerization, methyl transfer or sulfur
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insertion (7) through directed radical chemistry. In all these enzymes, a radical is
generated on a SAM molecule bound near the glycine rich domain through the
reductive properties of a Fe4S4 cluster ligated to the CxxxCxxC peptide
sequence. NifB is an interesting member of this superfamily, because it contains
two Fe4S4 clusters that are possibly fused through a likely radical based
mechanism with SAM to synthesize NifB-co, a FeMo-co precursor (8).
Comparative analysis of the nif, vnf and anf systems that code for the Mo-,
V- and Fe-only nitrogenases, respectively, have indicated that there are no
orthologues of nifB in the vnf or anf systems (9,10). In addition, gene knockouts
of nifB in A. vinelandii were shown to result in the inability of diazotrophic growth
regardless of the presence of Mo, V and Fe, suggesting that nifB may be shared
among the three different nitrogenase systems (11). Thus, an isolated form of the
nifB gene product was sought out to characterize the role of NifB in nitrogenase
biosynthesis. Early attempts by others at NifB purification focused on the ΔnifN K
pneumoniae strain, UN1217, which was shown to be able to complement the
ΔnifB A. vinelandii strain, UW45, in activation of the Mo-nitrogenase complex in
vitro. However, these early NifB purification attempts instead yielded a low
molecular weight product, designated NifB-co, that was also able to complement
UW45 in Mo-nitrogenase activation and was shown to be a FeMo-co precursor
through the observation of
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Fe or 35S radiolabel transfer (4,12). These

observations further stressed the need for NifB isolation and biochemical
characterization for a full biochemical understanding of the FeMo-co biosynthetic
pathway.
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Isolation of A. vinelandii NifB for biochemical studies has been
biochemically challenging. Two different approaches to purification have been
reported to isolate NifB but both have significant drawbacks. The first approach
utilizes a poly-His tag on NifB to allow for purification by immobilized metal
affinity chromatography (IMAC) (6). This procedure confronts the insolubility of
NifB through the use of the detergent, n-dodecyl-β-D-maltopyranoside. While the
poly-His tagged NifB has been shown to be active, low yields (reported as 20
mg/kg cells) and the presence of detergent at relatively high concentrations make
further characterization expensive, in terms of both time and cost, and is
ultimately unfeasible for long term biochemical studies. The second reported
approach fuses NifB with NifEN to mimic the native NifB-N fusion in Clostridium
pasteurianum (13). NifEN is also an essential enzyme in the FeMo-co
biosynthetic pathway and is thought to facilitate the maturation of NifB-co to
FeMo-co by a mechanism that is poorly understood. The purified NifEN-NifB
protein has been used in conjunction with

14

C-SAM to identify NifB as being

responsible for the insertion of the interstitial carbon atom (8). However, this
approach prevents the discrete biochemical characterization of NifB due to the
presence of the fused NifEN protein.
The FeMo-co maturation process, comprised of the synthesis of NifB-co
by NifB and the processing of NifB-co by NifEN and Fe-protein, has multiple
steps that are not well understood. NifB produces a cluster of unknown
composition, through an unknown mechanism, which is then processed by NifEN
to incorporate Mo and (R)-homocitrate, and possibly more Fe and S, into the
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cluster to yield FeMo-co by another mechanism that is also not well
characterized. To date, no NifB construct can effectively be used for high
expression, rapid purification and robust biochemical experiments to elucidate
these unknowns. The poly-His tagged NifB construct produces too low a yield to
feasibly allow approaching the problems, and the detergent hinders
characterization. The NifEN-NifB construct is a bigger “blackbox” than NifEN by
itself, and prevents the isolation of transient intermediates, such as NifB-co,
towards structural characterization and understanding of the NifB cluster
synthesis mechanisms. Clearly, a truly isolated NifB that is free of detergents is
required in order to approach these mysteries one at a time. Therefore, a new
construct for NifB fused to a highly soluble and readily purifiable protein is ideal.
A glutathione S-transferase (GST) fused form fits this description well and is an
ideal candidate for NifB fusion. Monomeric GST is a 25 kDa molecular weight
protein that is readily purifiable by affinity chromatographic methods (14,15). In
this chapter, an A. vinelandii strain was constructed to express GST-NifB upon
nif promoter derepression. The A. vinelandii extracts were shown to contain
functioning GST-NifB that was able activate the Mo-nitrogenase complex, and
was rapidly purifiable by GSH-Sepharose affinity chromatography.
Materials and Methods
Gene manipulation methods
The A. vinelandii gDNA was obtained using a DNeasy Blood and Tissue
kit (Qiagen). Primers were designed using Vector NTI software (Invitrogen) and
synthesized (Operon). PCR amplifications were performed using KOD or Taq
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polymerases (Novagen) in an Eppendorf Mastercycler. Amplicons were purified
with QIAquick PCR Purification kits (Qiagen) and quantified
spectrophotometrically at 260 and 280 nm. Amplicon sizes were confirmed using
agarose gel electrophoresis and were further confirmed by sequencing (Eton or
Genewiz). The pSTBlue and pET42 vectors were obtained from Novagen.
Restriction digestions and ligation reactions were performed using provided
buffers and protocols provided by the manufacturer (Fermentas, Finnzymes or
New England Biolabs). Products of digestion and ligation were purified using
QIAprep Spin Miniprep kits (Qiagen).
Generation of the A. vinelandii CF001 and CF002 Strain by Recombination
A. vinelandii strains, DJ1143 and DJ1041, were made competent by
growth in phosphate buffer (8 g/L K2HPO4, 2 g/L KH2PO4, pH 7.3), 130 mM
ammonium acetate, and competent salts (20 g/L sucrose, 0.2 g/L MgSO4●7H2O,
0.09 g/L CaCl2●2H2O, 1 mL/L of 0.25 mg/mL Na2MoO4●2H2O, 5 mg/L
FeSO4●7H2O) lacking Fe and Mo. The cells are grown for 18 - 20 hours at 30 ⁰C
while shaking at 170 rpm. The cells were then rescued by combining 200 µL of
culture with 200 µL of 1 X MOPS buffer (4.18 g/L MOPS, 4.5 g/L MgSO4●7H2O,
pH 7.2, filter sterilized) and 5 µL of suicide plasmid vector, and then plating onto
BN plates (Burke’s media supplemented with 1.3 mM NH4OAc). The cultures of
DJ1143 and DJ1041 treated by the suicide plasmid vector were then regrown
with BN media overnight at 30⁰C while shaking at 170 rpm. Transformed DJ1041
derived strains were selected on BNA (20 µg/mL ampicillin in BN), strain isolated,
and designated CF001. Transformed DJ1143 strains were selected on BNAK (20
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µg/mL ampicillin and 0.5 µg/mL kanamycin in BN), strain isolated, and
designated CF002. Proper recombination was confirmed by sequencing of PCR
products amplified from segments of genomic DNA of the derived strains.
Purification of Nif Proteins and NifB-co
All A. vinelandii strains were grown in modified Burke’s media in a 100 L
ferementor (BioEngineering). Expression of Nif proteins was induced by either
consuming or removing nitrogenous media components such as ammonium salts
or urea to derepress the nif promoter. Cells were harvested by a continuous flow
Sharples centrifuge.
All proteins were purified under an anaerobic Ar environment in a 4 ⁰C
cold room. A. vinelandii strains DJ1041, DJ884, DJ1143, and DJ995 were used
for purifications of NifEN, Fe-Protein, apo-MoFe-protein, holo-MoFe-protein,
respectively. Cell extracts were prepared by osmotic shock (16). Cells were first
resuspended into a hypertonic buffer (50 mM Tris HCl, 38 % glycerol, 2 mM
Na2S2O4, pH 7.9) and centrifuged for 40 min in a Beckman JA10 rotor at 9000
rpm to pellet the cells. The cell pellets were then homogenized with buffer of
normal osmolarity (50 mM Tris HCl, 0.1 mM PMSF, 5 µg/mL DNAse, 2 mM
Na2S2O4, pH 7.9) to lyse the cells. The extracts were clarified by centrifugation in
a Beckman Type19 rotor at 17,000 rpm for 1 hour.
NifEN, and both forms of MoFe-protein were purified with Zn2+ immobilized
metal affinity and ion exchange chromatography using published methods (17).
The Fe-Protein was purified using a series of ion exchange and gel filtration
chromatography steps described in past publications (18). Purified components
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were concentrated using a custom pressure cell fitted with a 100 kDa
ultrafiltration membrane (Millipore) and stored as frozen pellets in liquid N2.NifBco preparations are described in the methods section of Chapter 3.
FeMo-co Synthesis Assays
FeMo-co synthesis activity assays were performed in 9 mL serum vials
that were crimp sealed with a butyl rubber stopper. All vials were made anaerobic
by repeated cycles of degassing by vacuum and backfilling with Ar, and then
rinsed with anaerobic buffer containing 2 mM Na2S2O4. Reaction mixtures
contained 300 mM MOPS pH 7.0, 2.5 mM ATP, 37 mM phosphocreatine, 4.5 mM
MgCl2, 50 µg/mL creatine phosphokinase, and 2 mM Na2S2O4. Where
necessary, 175 µM (R)-homocitrate, 7.5 mM Na2MoO4, 130 µM SAM, 50 µM
(NH4)2Fe(SO4)2 and 50 µM Na2S were added. Enzyme components were
transferred into serum vials using gas tight syringes that were rinsed with
anaerobic buffer containing 2 mM Na2S2O4. Activation of apo-MoFe-protein, with
purified enzymes and UW45 extracts, was performed at 30 ⁰C for 30 min in a
total volume of 1.6 mL. Equal amounts of apo-MoFe-protein are used throughout
all assays for activity comparison. Nitrogenase activity was measured by H+
reduction to H2 and quantification of the H2 produced using a 5890 Series II HP
gas chromatograph fitted with a TCD and FID in conjunction with RT-QS-BOND
and Molesieve 13x 60/80 Restek columns.
Purification of GST-NifB
All chromatographic purification steps were performed using degassed
buffers kept under an anaerobic Ar atmosphere in a 4 ⁰C cold room. Cell extracts

54

were prepared from 30 g of CF002 cells and were loaded onto a GSH-Sepharose
column (2.5 cm x 10 cm, GE Healthsciences) that was previously equilibrated
with Buffer A (300 mM NaCl, 50 mM Tris-HCl, 2 mM Na2S2O4, 5 % (v/v) glycerol,
pH 7.3). The column was then washed with 5 column volumes of Buffer A to
remove non-specific proteins. The GST-NifB was eluted from the column by
washing with 5 column volumes of Buffer B (Buffer A + 15 mM GSH). The
combined eluent was concentrated anaerobically to 4.9 mg/mL in a custom
pressure cell fitted with a 30 kDa ultrafiltration membrane (Millipore). The
concentrated eluent was frozen as pellets and stored in liquid N2.
Protein Methods
Protein concentrations were determined by means of the Biuret reaction
(19). Purity of proteins were analyzed by standard SDS-PAGE and western blot
procedures (20,21). Western blots were visualized using goat anti-GST
antibodies as the primary antibody and biotinylated rabbit anti-goat antibody as
secondary antibody for standard streptavidine conjugated alkaline phosphatase
catalyzed hydrolysis of BCIP and color development of NBT. Peptide sequencing
was performed by the Proteomics core facility at UC Davis.
Results
Isolation of NifB for characterization requires fusion to a highly soluble
protein that will not affect the clusters present on NifB. GST-fusion is a suitable
means of NifB isolation for this purpose. To controllably express GST-NifB in the
absence of other Nif proteins, substitution of the nifHDKENX genes downstream
of the nif promoter was accomplished using a constructed suicide vector having
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the coding region for nifB fused in frame with the GST gene and flanked by
appropriate sequences to allow double homologous recombination. The nif
promoter is under the control of the NifL and NifA transcriptional regulators that
sense levels glutamine (22). High levels of glutamine lead to the repression of
the nif promoter by NifL, resulting in repression of expression for proteins that are
downstream of the nif promoter site. Low levels of glutamine lead to the
derepression of the nif promoter and expression of gene products downstream of
the nif promoter. Therefore, replacement of the genes downstream of the nif
promoter with GST-nifB would allow for controllable expression of GST-NifB
through the presence or absence of fixed nitrogen molecules in culture media.
Toward this aim, A. vinelandii nifB was cloned into the pET42 vector having a
GST gene. Multiple DNA manipulation steps were then performed to yield a
modified pSTBlue vector, designated “suicide” vector, that contains the GST-nifB
gene flanked by sequences homologous to the beginning and end of the
nifHDKENX gene cluster, described below.
Construction of the A. vinelandii GST-nifB vectors
The nifB region of the A vinelandii genome was amplified by PCR from A.
vinelandii gDNA using primers 011MLJ and 012MLJ, then cloned into the EcoRI
site of pSTBlue. The coding sequence for A. vinelandii nifB was then amplified
using primers 134JG and 158JG from the newly constructed vector and subcloned into the BspHI and HinDIII restriction sites of pET42 to produce a vector
coding for a GST-nifB fusion gene, pJG50. In a similar fashion, pJG51 was
constructed to code for a fused poly-His tag to the C- terminal end of GST-NifB
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by replacing primer 158JG with 129JG. A second series of vectors were
constructed towards the generation of a suicide vector that would be used for A.
vinelandii transformations (Figure 12).

Figure 12 : Diagram of Suicide Vector Synthesis
Stepwise construction of the suicide vector starting from commercial pSTBlue.(A) Deletion of
ampR. (B) Reinsertion of ampR into multiple cloning site. (C) Insertion of Pnif sequence. (D)
Insertion of nifX sequence. (E) Insertion of GST-nifB sequence.

First, the ampR gene from within pSTBlue was deleted using primers 180TJC,
181TJC to produce pTC57 (Figure 12A). The ampR gene was then reinserted
into the BsiWI and EcoRV restriction site of pTC57 using primers 294TJC and
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295TJC to yield pTC66 (Figure 12B). A segment of the nif promoter was then
amplified from A. vinelandii gDNA using primers 186TJC and 303TJC and
inserted directly upstream of ampR within pTC66 at the KpnI and NdeI restriction
sites to produce pTC67 (Figure 12C). Next, a portion of the nifX gene was
subcloned directly downstream of ampR at the XhoI restriction site using primers
365TJC and 250TJC to produce pTC69 (Figure 12D). In the final step, the GSTnifB gene was subcloned from pJG50 into the AvrII and NdeI restriction sites
directly downstream of the nif promoter in pTC69 using primers 244TJC and
362JG to produce the GST-nifB recombination suicide vector (Figure 12E).
Construction of A. vinelandii Strains for Expression of GST-NifB
A. vinelandii strains, DJ1143 and DJ1041 were chosen as candidates for
transformation. DJ1041 is a ΔnifHDK mutant that expresses a poly-His tagged
NifEN through nif promoter depression and was chosen for higher probability of
successful transformation relative to wildtype due to the short sequence between
the recombination sites. DJ1143 has kanR inserted within the genomic nifB and
expressed poly-His tagged apo-MoFe-protein upon nif promoter derepression,
and was chosen due to lack of endogenous NifB expression. Double
recombination of the genes between the nif promoter and nifX in both DJ1041
and DJ1143 with those of the suicide vector should yield strains that express
GST-NifB during nif promoter derepression without expression of the nifHDKENX
gene cluster products (Figure 13).
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Figure 13 : GST-NifB Recombination into the A. vinelandii Genome
Genomic DNA is colored in blue and vector DNA is colored in red. Recombination at both the Pnif
and nifX genes yields new strains CF001 or CF002. Primers are depicted as bent arrows. Primers
depicted as green arrows are used to check for front end recombination by sequencing. Primers
depicted as purple arrows are used to check for back end recombination by sequencing.

However, a single recombination derivative is also possible, and would
result in a strain that retains the gene cluster between the nif promoter and nifX
genes while assimilating the suicide vector plasmid into the single recombination
site. Double and single recombination for DJ1041 was discriminated by checking
for selective growth in media containing ampicillin and kanamycin. In addition to
ampR, the suicide vector also contains a kanR gene located outside of the
recombination target sequence that could only be incorporated into the A.
vinelandii genome during single recombination. Therefore, a DJ1041 double
recombinant would be able to grow on media plates containing ampicillin but not
kanamycin. Indeed, the DJ1041 double recombinant, designated CF001, was
verified by colonies that are able to grow on BNA plates but not on BNK or BNAK
plates. In contrast, the DJ1143 double recombinant cannot be checked by this
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method because the genome contains a kanR insertion within the endogenous
nifB gene, and would thus produce a false negative result. To verify the double
recombination into the genetic background of DJ1143, PCR analysis was
performed using appropriate primers to analyze the genomic sequence of
candidate colonies. The formation of a PCR amplicon when forward primer
383JG binds to a sequence upstream of the nif promoter and reverse primer
364JG binds within genomic GST-nifB indicates that recombination has occurred
at the nif promoter site (Figure 14, lane 4).

Figure 14 : PCR Screen for Double Recombination in CF001 and CF002
Shown is an agarose gel visualized by UV irradiation. Lanes contains (1) DNA Ladder, (2) CF001
front end recombination PCR amplicon, (3) CF001 back end recombination PCR amplicon, (4)
CF002 front end recombination PCR amplicon, (5) CF001 back end recombination PCR
amplicon, Primers 383JG and 364JG were used for amplification screening of front end
recombination, whereas primers 181TJC and 384JG were used for amplification screening of
back end recombination.

Another PCR based confirmation of a PCR amplicon yielded using forward
primer 181TJC that binds to the genomic ampR gene and reverse primer 384TJC
that binds to genomic sequence downstream of nifX indicates that the candidate
colony was a DJ1143 double recombinant (Figure 14, lane 5). The DJ1143
double recombinant was designated CF002.
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Expression of GST-NifB in CF002
Within the CF001 strain, endogenous NifB is expressed in addition to
recombinant based GST-NifB, due to the DJ1041 background mentioned before.
Thus, CF001 may yield heterodimeric complexes with GST-NifB and non GSTfused NifB. In contrast, the CF002 background strain, DJ1143, has a kanR
inserted within the native genomic nifB that prevents expression of functional
non-GST fused NifB, and thus CF002 will only express nif promoter controlled
GST-NifB. Therefore, CF002 was used for all subsequent experiments.
Expression of nif regulated GST-NifB in CF002 is compared against the
background strain, DJ1143, and expression of GST-NifB was assessed by
western blot analysis of whole cell extracts using an anti-GST antibody ().

Figure 15 : Anti-GST Western Blot Analysis of CF002 Expression
Lanes contain (1 and 9) Molecular weight markers, (2) GST-NafY for reference, (3) nif repressed
DJ1141, (4) nif repressed CF002, (5) pre-nif derepression DJ1141, (6) pre-nif derepression
CF002, (7) post-nif derepression DJ1141, (8) post-nif derepression CF002. The 85 kDa protein
band was observed only in nif derepressed CF002 and later confirmed to be GST-NifB.

Results indicate the presence of a protein of approximately 85 kDa that is
reactive with the anti-GST antibody and is only present in the derepressed
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CF002 extract sample (Figure 15, lane 8). This molecular weight matches the
combined molecular weights of NifB, 55 kDa, and GST, 25 kDa.
CF002 Extracts are Able to Activate the Mo-nitrogenase Complex
In the absence of N2 and other substrates, the Mo-nitrogenase complex
will reduce H+ to H2, which can be quantified by gas chromatography. When
provided with excess Fe-protein, the specific activity of limiting amounts of holoMoFe-protein can then be determined by quantifying the H2 formed. In this
section, biochemical assays for maturation of a fixed amount of apo-MoFeprotein, in the presence of extract from the ΔnifB A. vinelandii mutant, UW45,
were conducted by complementing with purified NifEN, isolated NifB-co or CF002
extract to produce an activate Mo-nitrogenase complex. Activity of the activated
Mo-nitrogenase complex was measured by quantification of H + reduction activity.
Nitrogenase H+ reduction activity was observed to linearly increase with the
addition of NifEN to the biochemical complementation assays (Figure 16).

Figure 16 : NifEN dependent apo-MoFe-protein Specific Activity
Data points are indicated by triangles, where the vertical bars represent error.
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This result validates the in vitro FeMo-co synthesis assay. The NifEN was
purified from the DJ1041 strain that contains an active endogenous NifB, which
produces a FeMo-co precursor that is present on the NifEN. The in vitro
synthesis of FeMo-co using isolated NifB-co as a precursor to biochemically
complement a reaction with limiting NifEN as an enzymatic catalyst is also
possible. As shown, addition of purified NifB-co allows for the activity to initially
increase, and then decrease (Figure 17). This decrease of activity with the
addition of greater than 1 nmol of NifB-co is likely due to the presence of
detergent in the NifB-co preparations, which has an inhibitory effect.
Nonetheless, the presence of in vitro FeMo-co synthesis activity with NifB-co as
a starting substrate is significant, because such a reaction allows for the
measurement of NifB enzymatic activity that forms NifB-co.

Figure 17 : NifB-co dependent apo-MoFe-protein Specific Activity
Data points are indicated by triangles, where the vertical bars represent error.

With the optimization of an in vitro FeMo-co synthesis reaction using NifB-co as a
precursor, this allows for a method to assay NifB activity. This assay was used to
measure the NifB activity in the extract of CF002 cells. Addition of CF002 extract
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to the in vitro FeMo-co synthesis reaction in lieu of NifB-co does indeed show
activity. Comparison of Mo-nitrogenase activation by the various components is
summarized in Table 1.
Table 1 : Summary of Activities for Mo-nitrogenase Activation Components

Mo-nitrogenase Activation Assay
Cluster Source
holo-MoFe-protein
NifEN

Sp. Activity (nmol H2/min/mg)
406 ± 11
477 ± 101

NifB-co

Sp. Activity (nmol H2/min/nmol)
37 ± 17

CF002 extract

Sp. Activity (nmol H2/min/mL)
108 ± 37

Activation of the Mo-nitrogenase complex by the CF002 extract in the absence of
NifB-co indicates that the overexpressed GST-NifB in CF002 was functional and
was able to synthesize NifB-co, which was processed and matured to FeMo-co
by NifEN contained in the UW45 extract.
Purification of GST-NifB from CF002 Extract
A small scale purification of GST-NifB protein from derepressed CF002
cells was attempted by GSH-Sepharose affinity chromatography. After loading of
the cell extract, the accumulation of a golden tinted product at the head of the
column was observed, indicating the buildup of a protein likely containing an FeS clusters. Subsequent addition of buffer containing GSH eluted the golden tinted
product. This protein was then analyzed for purity and molecular weight by
standard SDS-PAGE. The eluted protein product was similar in size to the band
detected by western blot analysis of derepressed CF002 (Figure 18, lane 2). The
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smaller bands were likely unfused GST and native A. vinelandii GST that
apparently co-purified. MALDI-TOF based proteomics analysis confirmed that the
large molecular weight product was GST-NifB. With the isolation of GST-NifB
from CF002, every component of the A. vinelandii Mo-nitrogenase biosynthetic
pathway has been purified in the laboratory (Figure 19). This would allow in vitro
reactions to be performed for biochemical analysis of the entire reaction to
synthesize FeMo-co.

Figure 18 : SDS-PAGE Analysis of CF002 GSH-Sepharose Elution
Lanes contain (1) molecular weight markers and (2) eluent from the GSH-Sepharose affinity
chromatography of nif derepressed CF002 extract. The large molecular weight product at 85 kDa
was sent out for mass spectroscopic proteome analysis and confirmed to be GST-NifB.
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Figure 19 : Combined SDS-PAGE of Mo-nitrogenase Biosynthesis Component Enzymes
Shown is the SDS-PAGE containing samples of all purified Mo-nitrogenase biosynthesis
component. Lanes contain (1) molecular weight markers, (2) Fe-protein, (3) apo-MoFe-protein,
(4) NifEN, (5) NifX, (6) NifU, (7) NifS, (8) NifV, (9) GST-NifB, and (10) NafY.

Discussion
Specific unknowns regarding NifB include the source of the NifB Fe 4S4
clusters, the identity of the NifB reductase, the mechanism for NifB-co synthesis,
and the exact structure of product NifB-co. The challenge of answering these
questions was due to the lack of a method for rapid purification of readily
expressed and soluble NifB.
While previous isolations of NifB have been reported, they cannot be used
for discrete biochemical characterization of NifB due to the fused presence of
NifEN or limitations in yield and cost. The work presented in this chapter shows
the isolation of soluble NifB, free from the presence of detergents and separated
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from NifEN, expressed as a GST-fused protein by derepression of the A.
vinelandii strain CF002. Generation of CF002 was accomplished by the
construction of a suicide plasmid vector that contained the GST-nifB fusion gene
flanked by the sequences that are homologous to regions of the A. vinelandii nif
promoter and nifX gene. This suicide vector was used to facilitate transformation
of DJ1143 through double recombination to substitute the nifHDKENX gene
cluster with GST-nifB. The DJ1143 double recombinant, CF002, was verified by
targeted PCR amplifications. Western blot analysis of nif promoter derepressed
CF002 with anti-GST antibodies indicated the expression of a protein product
that matched the GST-NifB combined molecular weight. To assay for the
presence of NifB-co synthesis activity by GST-NifB in CF002 extracts, an in vitro
FeMo-co synthesis reaction was optimized to use NifB-co as a precursor with
limiting amounts of NifEN as an enzymatic catalyst. This allowed for the
confirmation of NifB activity in CF002. Sequential purification of GST-NifB from
CF002 was achieved by GSH-Sepharose affinity chromatography and verified by
mass spectroscopic analysis of the eluted product.
The isolation of GST-NifB was the necessary step in further
characterization of the FeMo-co biosynthetic pathway. Now that all components
have been isolated, experiments may be designed towards elucidating the
unknowns of FeMo-co biosynthesis. One such noteworthy unknown is the
structure NifB-co, which is the product of NifB and essential precursor for the
biosynthesis of FeMo-co. GST-NifB reactions containing with 14C methylated
SAM and NifX could be used to probe for the presence of a central carbon atom
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in NifB-co. A NifX●14C-NifB-co product could then be used as a precursor in the
FeMo-co synthesis assay to confirm NifB-co as the first cluster to contain the
FeMo-co interstitial carbon. These results would be an important step in
developing the understanding of NifB-co.
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CHAPTER 3: EXAFS OF NIFB-CO IN THE PRESENCE OF
SELENOL-MOFIDIED LIGANDS
Abstract
NifB-co is an isolatable low molecular weight Fe-S cluster product of
catalysis by the NifB enzyme and has been shown to be an early precursor to the
Mo-nitrogenase active site metal cluster, FeMo-co. NifB-co is very susceptible to
oxidative damage and is a labile intermediate in the pathway for FeMo-co
synthesis, between the step performed by NifB and further maturation by NifEN.
Electron Paramagnetic Resonance (EPR) spectroscopy is often a choice method
for characterization of Fe-S clusters, but NifB-co is EPR silent. Furthermore, the
lack of X-ray crystallographic based structural information makes NifB-co even
more difficult to understand. Based on recent Extended X-ray Absorption Fine
Structure (EXAFS) and Nuclear Resonance Vibrational Spectroscopy (NRVS)
analysis, a Fe6S9C cluster has been suggested to comprise the core of NifB-co.
However, the data suggests the presence of more Fe-S interactions that are not
completely fit by the 6-Fe NifB-co model, likely because they are contributed from
bound DTT and cysteines from NifX. Here, the previous EXAFS experiment is
expanded to include NifB-co interactions with bound DTT, NifX, diselenothreitol
(DSeT) and SeCys-NifX to better fit the data and characterize the number of
ligand binding sites on NifB-co. Analysis of ligand contributed Fe-S and Fe-Se
interactions suggests that six ligand binding sites on NifB-co are bound by μ2S
atoms from DTT and NifX. Samples containing heterogeneous ligands types
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indicate that S atoms from four NifX cysteines are accompanied by 2 S atoms
from DTT during mixed ligand binding.
Introduction
NifB-co is an isolatable low molecular weight Fe-S cluster product of NifB
that is processed by the joint activities of NifEN and Fe-protein to become the
Mo-nitrogenase active site metal cluster, FeMo-co. NifB-co is very susceptible to
oxidative damage and is a labile intermediate in the pathway for FeMo-co
synthesis between the steps performed by NifB and further maturation by NifEN.
NifB-co is isolated primarily from a Nif(-) phenotype Klebsiella pneumoniae strain
UN1217, containing a ΔnifN mutation (1,2). Past experiments have shown that
UN1217 extracts are able to complement extracts of UW45, an A. vinelandii
strain containing a mutation in nifB, in vitro to allow FeMo-co synthesis and
activation of the Mo-nitrogenase complex. This activity in extracts of K.
pneumoniae UN1217 to complement the deficiency in UW45 extracts indicates
the presence of an active NifB in UN1217. For this reason, the isolation of NifB
enzyme from UN1217 was previously attempted. Instead of isolating the NifB
enzyme, a low molecular-weight Fe-S cluster, designated NifB-co, was isolated
and verified to also be able to complement UW45 extracts for in vitro FeMo-co
synthesis activity (3). Experiments using 55Fe or 35S labeled NifB-co clearly show
that Fe and S as part of NifB-co are specifically incorporated into FeMo-co (4). In
the NifB-co maturation process, NifX is thought to chaperone NifB-co to NifEN,
where NifB-co is further processed to become FeMo-co (5). The only structural
characterization of NifB-co comes from comparative Extended X-ray Absorption
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Fine Structure (EXAFS) analysis of NafY bound FeMo-co with NifX bound NifBco. Hypothetical models for NifB-co structures composed of 6-, 7- or 8-Fe atoms,
modeled from the core of FeMo-co, were used to fit the collected EXAFS data.
This analysis showed that the model of a 6-Fe cluster best fit the collected
EXAFS data (6). The EXAFS experiment, coupled with recent evidence of the
central atom of FeMo-co being a carbon atom derived from the methyl group of
SAM (7,8), imply that NifB-co has a Fe6S9C cluster at its core.
As mentioned in Chapter 1, NifB is a radical SAM superfamily member
that probably directs radical chemistry towards fusing two Fe4S4 clusters to
become NifB-co. The recently discovered function of NifB as an interstitial carbon
insertase implies that NifB-co is likely the first cluster to contain the interstitial
carbon (8). The determination of NifB-co structure is an important step in
understanding the mechanism of NifB catalysis, as it will provide insight on how
NifB performs radical chemistry catalysis to yield this FeMo-co precursor. Though
the previous EXAFS experiment determined that the 6-Fe model is the best fit,
the 7- and 8- structures are still possible fits. Since there previously was
absolutely no structural information, a 6-Fe model structure for NifB-co was a
significant step forward. A better refined structure of NifB-co is necessary to
understand the reactivity of NifB-co, to study how NifB synthesizes NifB-co, and
to probe how NifEN alters NifB-co in the subsequent step of the FeMo-co
biosynthesis pathway. A detailed analysis of the previous EXAFS experiment
shows that the intensity for the ~2.3 Å Fe-S interactions are not fully accounted
for with the 6-, 7- or 8-Fe models. Assessing the ligand environment of NifB-co is
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key to determining the whole structure of NifB-co and also for understanding the
reactive sites on NifB-co. These extra Fe-S interactions are likely contributed by
ligands bound to NifB-co. In the NifX bound NifB-co sample, the thiols of
cysteines that ligate to the cluster would contribute such Fe-S interactions to the
overall EXAFS spectrum. There are also likely to be dithiothreitol (DTT)
molecules bound to NifB-co as a ligand in the absence of NifX. DTT is required
for the solubilization of NifB-co as part of the purification procedure. The
presence of DTT as a ligand would also contribute an Fe-S interaction to the
overall EXAFS spectrum. DTT is also a possible ligand in the NifX bound NifB-co
samples. However, EXAFS would not be able to distinguish the Fe-S interaction
contribution of cysteine from DTT if both are present as ligands.
Characterization of NifB and NifB-co have been challenging due to the
complications from isolation and susceptibility to oxidative degradation. As part of
Chapter 2, new methods have been developed to isolate NifB for
characterization. However, understanding NifB-co requires a creative means of
characterization because typical techniques are complicated by the properties of
NifB-co. NifB-co is apparently EPR silent and therefore cannot be characterized
by advanced electronic magnetic resonance spectroscopies such as ENDOR or
ESEEM. Elemental analysis is not possible, because NifB-co cannot be prepared
as a solvent-free neat sample. NifB-co is not amenable to mass spectroscopy
analysis since ionization will cause decomposition of NifB-co and mass analysis
of breakdown products in the presence of detergents, ligands, or protein
environment. Lastly, X-ray crystallographic analysis has not been possible,
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because crystals of NifB-co are not possible to obtain due to the presence of a
high concentration detergent in NifB-co samples, nor is it possible to crystallize
NifB-co bound proteins. Therefore, we have opted to expand analysis by EXAFS
to further obtain structural and ligand information for NifB-co.
The EXAFS technique is based on the energy dependent and elemental
specific absorption of X-ray photons (9). The X-ray absorption spectra observe a
large absorption peak, referred to as an edge, that is representative of the
ejection of a core electron from the absorbing atom. Each element requires a
specific energy for this core electron ejection, and small changes in the energy
range and shape of the absorption edge reveal information about the oxidation
state and geometric information of the specific absorbing atom. In the region past
the absorption edge, higher energy photon absorption results in the ejection of a
photoelectron with increased kinetic energy. Photoelectrons emitted from the
absorbing atom are then scattered by surrounding atoms, where backscattered
photoelectrons modulate the absorption coefficient of the initial X-ray absorbing
atom. Backscattered photoelectrons with different kinetic energies, and thus
different amplitudes, produce a sine wave like modulation of the absorbance
spectra. The frequency, amplitude and phase of the sine wave like modulation
can be used to determine the distance, coordination number and type of the
surrounding atoms. However, EXAFS only provides radial information about the
backscattering atoms. This means that two backscattering atoms of the same
element from different molecules cannot be distinguished from one another if
they are equidistant from the absorbing atom. For example, if ligated S atoms
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from both a cysteine and from DTT are equidistant from Fe atoms in NifB-co,
then their contribution would be averaged and thus indistinguishable. The same
applies if the S atom from ligands and the bridging S atoms from within NifB-co
are equidistant to the absorbing atom. Therefore, in order to use EXAFS to
distinguish heterogeneous Fe-S interactions and to determine how many ligand
binding site are available on NifB-co, the backscattering atoms around Fe must
somehow be differentiated from one another.
One way to differentiate the heterogeneous S atoms around the Fe atoms
for improved EXAFS characterization is to use selenium modified ligands.
Altering the elemental identity of the backscattering ligand atoms from that of
internal NifB-co atoms will provide insight as to how many ligand binding sites
are available on NifB-co. Additionally, this will allow for a more optimized fit of
NifB-co models to collected data because all Fe-S interactions will be contributed
solely by the cluster while all Fe-Se interactions will be contributed solely by
ligands. Furthermore, modifying the elemental identity of one ligand at a time will
provide insight as to how many of each ligand binds to the total number of
binding sites on NifB-co. This chapter focuses on the EXAFS characterization of
NifB-co bound ligands altered between S or Se with to DTT, NifX, diselenothreitol
(DSeT), SeCys-NifX and any combination thereof to determine the number and
type of ligands that bind NifB-co for the goal of determining a more refined
structural model for NifB-co.
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Methods
Expression of NifX and SeCys-NifX
The A. vinelandii genomic region containing nifX was PCR amplified from
gDNA with forward primer 028MLJ and reverse primer 029MLJ, and then ligated
into the EcoRV site of pSTBlue (Novagen) to yield pMJ50. A. vinelandii nifX was
then sub-cloned from pMJ50 to a pET15 vector (Novagen) using forward primer
047MLJ and reverse primer 048MLJ, followed by digestion with XhoI and NdeI,
and subsequent ligation to yield pMJ51. BL21 Escherichia coli was then
transformed with pMJ51 for expression of NifX. Construction of plasmid vectors
was confirmed by standard restriction mapping techniques and DNA sequencing
(Eton or Genewiz).
BL21 E. coli strains transformed with pMJ51 were grown at 37 ⁰C to an
optical density (OD600nm) of ~0.8 in LB broth containing 50 μg/mL ampicillin.
Expression of NifX was induced with the addition of 1 mM IPTG and cultured for
an additional 4 hours, followed by harvesting of the cells by centrifugation and
storage at -80 ⁰C.
The expression of SeCys containing NifX was achieved using a ΔcysE
BL21 E. coli cysteine auxotroph, which was generously provided by Dr. MariePaule Strub of NIH/NHLBI. The ΔcysE BL21 Cys auxotroph was transformed
with pMJ51 by traditional methods with CaCl2 and heat shock (10). Cultures of
the transformed Cys auxotrophic strain were grown in M9A media (M9 minimal
containing 50 μg/mL ampicillin (11)) supplemented 100 μg/mL Cys until desired
optical densities of 1.0 were achieved. Cells were then pelleted, resuspended
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with new M9 media and re-pelleted to wash residual cysteine. Washed cells were
resuspended into M9A media containing 100 μg/mL SeCys (Sigma) and
expression of NifX was induced with 1 mM IPTG. After a 9 hour induction, cells
were collected and frozen in liquid N2.
Purification of Wildtype and SeCys-NifX
All purification steps were performed in a 4 ⁰C cold room. The same
procedure was used to purify both wildtype and SeCys NifX. Cells were
resuspended into Buffer A (50 mM Tris-HCl, 150 mM NaCl, 10% glycerol, pH 7.9)
containing 5 μg/mL DNAse and 0.2 mM PMSF for sonication inside an anaerobic
chamber. Then, resuspended cells were sonicated for 5 rounds of 1 min intervals
while on ice. The soluble portion of crude extracts was retained after
centrifugation in a Beckman Type 19 rotor at 14,000 rpm for 1 hour. The soluble
portion was passed through a chelating Sepharose column ( 2.5 cm x 19 cm)
charged with Ni2+ and equilibrated with Buffer B (Buffer A + 1% Triton X100). The
column was then washed with three column volumes of Buffer B and eluted with
three column volumes of Buffer C (Buffer A + 250 mM imidazole). To remove
possible Ni2+ in solution, 1 mM EDTA was added to the eluent. The eluent was
then concentrated by ultrafiltration with a membrane having a 10 kDa cutoff. All
steps from this point on were performed under an anoxic Ar environment. The
concentrated protein sample is passed through a G10 Sephadex column
equilibrated with Buffer D (25 mM MOPS, 100 mM NaCl, 10% glycerol, 2 mM
Na2S2O4, pH 7.5) for buffer exchange to separate NifX from imidazole. The
collected fractions containing NifX are then concentrated as described before
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and quantified by means of the Biuret reaction (12). In total, 65 mg of NifX was
yielded from 30 g of cells and 16.25 mg of Se-Cys NifX was yielded from 25 g of
cells.
Preparation of NifB-co
NifB-co purification is performed using anaerobically grown and
derepressed K. pneumoniae UN1217 cells. All purification steps were carried out
under an anoxic Ar environment. UN1217 cells were resuspended into Buffer E
(100 mM Tris-HCl, 5 mM Na2S2O4, pH 7.6) containing 5 μg/mL DNAse, 0.2 mM
PMSF, and 0.5 μg/mL leupeptin. Then, the resuspension was anaerobically lysed
with a French pressure cell operating at 16,000 psi and frozen overnight. The
frozen UN1217 lysate was thawed and centrifuged in a Type 19 rotor at 18,000
rpm for 40 min. The pellet was then homogenized with Buffer F (Buffer E + 2%
Triton) and repelleted. The second pellet was homogenized with Buffer G (Buffer
E + 1 M NaCl) and repelleted. The third pellet was homogenized with Buffer H
(Buffer E + 1% Sarkosyl) and repelleted. The subsequent supernatant from final
centrifugation was retained and stored frozen overnight. The Sarkosyl treated
extract is thawed, supplemented with 5 mM DTT, and incubated for 30 min with
stirring. The Sarkosyl-DTT extract was then loaded onto a Sephacryl S-200
column equilibrated with Buffer I (50 mM MOPS, 1 mM DTT, 0.1 M NaCl, 0.4%
Sarkosyl, 2 mM Na2S2O4, pH 7.5). Once all of the extract had been loaded, the
column was washed with three column volumes of Buffer J (Buffer I – 0.4%
without Sarkosyl). Column bound NifB-co was then eluted with Buffer K (Buffer J
+ 2% sulfobetain SB-12). The NifB-co eluent was frozen and stored in liquid N2.
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DSeT bound NifB-co was prepared using the same procedure as regular NifB-co
with DSeT in place of DTT. Oxidized DSeT was synthesized by published
methods (13) and verified by GCMS and NMR. The oxidized DSeT was reduced
with NaBH4 in methanol immediately prior to use. Purified NifB-co was quantified
by determination of total Fe concentration through a colorimetric assay (14).
Typical concentrations ranged between 0.2 mM to 0.7 mM of NifB-co, assuming
6-Fe per NifB-co molecule. NifB-co and DSeT NifB-co were observed to retain
comparable activity in complementation assays with UW45.
EXAFS Sample Preparation
There were six different NifB-co samples in total. Sample 1 consisted of
purified NifB-co with bound DTT. Sample 2 consisted of NifB-co bound to NifX in
the presence of DTT. Preparation of the NifX●NifB-co complex was achieved by
loading NifB-co onto a Phenyl Sepharose column equilibrated with Buffer J and
washing to remove detergent, followed by elution with purified NifX. Sample 3
consisted of as NifB-co purified using DSeT instead of regular DTT (NifBco●DSeT). Sample 4 was prepared in the same manner as sample 2 with
SeCys-NifX in place of NifX and DSeT in place of DTT. Sample 5 was prepared
in the same manner as sample 2 with SeCys-NifX in place of NifX. Sample 6 was
prepared in the same manner as sample 2 with DSeT in place of DTT. All
samples were concentrated to ~5 mM by ultrafiltration, injected into 3 x 20 x 2
mm Lucite cells and slowly frozen in liquid N2.
EXAFS Data Collection
Fe K-edge EXAFS data was collected at the Stanford Synchrotron
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Radiation Laboratory beamline 7-3. Beamline 7-3 is equipped with a Si 220
double-crystal monochromator and a flat, bent, vertically collimating, rhodiumcoated mirror. A Canberra Industries 30 element Ge fluorescence detector fitted
with Soller slits and a Mn filter allows for the detection of X-ray fluorescence with
minimal scattering. The samples were kept at 9 K with a liquid helium cooled
cryostat during data collection. Two N2 ionization gas chambers were used to
measure the source and transmitted light. The X-ray energy was calibrated by
the first inflection point of a standard Fe foil at 7112 eV. Samples were robotically
moved between each scan so that the path of irradiation passed through different
spots to prevent photodegradation. Each sample was scanned 4 times.
EXAFS Data Analysis
The EXAFSPAK software suite OPT and MULDAT applications were used to
analyze EXAFS data and produce figures (15). The past NifX bound NifB-co and
selenol ligand bound FeMo-co data (6,16) were used as references for
experimentally determined Debye-Waller factors (σ). Additionally, OPT was used
to perform search profiles to acquire approximated distances (R) and DebyeWaller factors for a long distance S-Fe interaction. Models were fit to the
experimental data using the EXAFS equation in Equation 2. Routines consisting
of floating R, Debye-Waller factor, and ΔE0 followed by floating N for short range
S-Fe or Se-Fe interactions allowed for structures to be optimized to a good fit.
The goodness of fit was measured by the F-factor listed in Equation 3, which is
an EXAFS analog to the crystallography R-factor.
Equation 2 : EXAFS Equation
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( )

∑

(

Where NX is the number of X atoms in the shell,
factor,

( ))

(2)

is the amplitude reduction

( ) is the amplitude function, k is the photoelectron wave number, R is

the distance between the absorbing and backscattering atom pair, σ is the root
mean square of the distance known as the Debye-Waller factor, and

( ) is

the phase function fo the absorber and backscatterer pair.
Equation 3 : F-factor

(

∑

(
∑

)
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)

Where k is the photoelectron wave number,
determine k3 weighted data, and

is the experimentally

is the k3 weighted value calculated from

the model.
Results
Search Profiles Indicate a Second Shell Fe-S Interaction
The previous Fe K-edge EXAFS experiment set the stage for further NifBco characterization by specifically fitting the Fe-S, Fe-central atom, and Fe-Fe
interactions of the 6-, 7-, and 8-Fe models. Radii and Debye-Waller factors of
interactions optimized in the prior NifB-co models were used as starting points for
fitting routines (6). However, the earlier EXAFS experiment provided only partial
characterization of the first shell Fe-S interactions. These first shell Fe-S
interactions are comprised both from within the cluster and from ligands. To
deduce the total number of first shell Fe-S interactions, possible second shell FeS interactions, which are only from within the cluster, need to be included to
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deconvolute the data contributed from all the backscattering S atoms. For this
reason a “search profile” was used to address the presence of second shell Fe-S
interactions. Search profiles map the goodness of fit, calculated by the F-value in
Equation 4, as color coded plots or three dimensional contour maps for the plots
of two curve fitting parameters, and thus “visualize” the regions of best fit.
Equation 4 : F-value for Search Profiles

(∑(

)

(4)

Where k is the photoelectron wave number,

is the experimental data and

is

the calculated data
For sample 1, which consisted of as-purified NifB-co in DTT (NifB-co), a
search profile of a second shell Fe-S interaction between the distance vs. DebyeWaller factor shows a trough at 4.07 Å and indicates the validity of including a
second shell Fe-S interaction for modeling and fitting the data (Figure 20).
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Figure 20 : Search Profile for the Second shell Fe-S Interaction in NifB-co
2
Shown is the three dimensional distance(R) vs. Debye-Waller factor (σ ) search profile for the
second shell Fe-S interaction in NifB-co. The F-value measures the goodness of fit and is
calculated by Equation 4. Here, the ~4.1 Å distance value portrays a deeper trough at reasonable
2
σ values.

This was similarly observed in sample 2, which consisted of NifB-co bound to
NifX in DTT (NifB-co●DTT●NifX). However, the search profiles for analysis of
data for NifB-co●DSeT indicate a better fit at 4.4 Å (Figure 21). Therefore, all
subsequent data analysis used either five or six components representing
discrete backscatter interactions to model the 6-Fe NifB-co model structure by
including 1) first shell Fe-S interactions around ~2.3 Å, 2) second shell Fe-S
interactions at ~4.0-4.4 Å, 3) first shell Fe-Fe interactions at ~2.6 Å, 4) second
shell Fe-Fe interactions at ~3.7 Å, 5+ the Fe-C interactions at ~1.9 Å, and 6) the
Fe-Se interactions at ~2.4 Å appropriately for samples that contained Se.

Figure 21 : Search Profile for the Second shell Fe-S Interaction in NifB-co●DSeT
2
Shown is the three dimensional distance(R) vs. Debye-Waller factor (σ ) search profile for the
second shell Fe-S interaction in NifB-co●DSeT. The F-value measures the goodness of fit and is
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calculated by Equation 4. In contrast to NifB-co, this sample (and all other selenium containing
2
samples) portrays the ~4.4 Å distance as a deeper trough with reasonable σ values.

Samples Containing Only Thiol Ligands Suggest Twelve Fe-ligand Interactions
Parameters of the first shell Fe-S interaction were allowed to float during
fitting routines. Specifically, the N value was allowed to float in conjunction with
the distances and Debye-Waller factors of all individual components. The
resulting parameters from fitting of the EXAFS data for NifB-co and NifBco●DTT●NifX are provided in Table 2.

Table 2 : Curve Fitting Parameters for Samples Containing Only Thiol Ligands
EXAFS curve fitting parameters where N is the number of backscattering atoms, R is the distance
between absorbing and backscattering atoms, σ is the Debye-Waller factor, ΔE0 is the
photoelectron threshold energy, and F is the goodness of fit as calculated by Equation 3
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st

Fe-S (1 Shl)
Fe-S (2

nd

Shl)

Fe-Se
st

Fe-Fe (1 Shl)
Fe-Fe (2

nd

Shl)

Fe-C
ΔE0 (eV)
F

Sample 1

Sample 2

NifB-co●DTT

NifB-co●DTT●NifX
2

2

2

2

N

R (Å)

σ (Å )

N

R (Å)

σ (Å )

5

2.25

0.0065

5

2.26

0.0077

3

4.07

0.0052

3

4.08

0.0097

-

-

-

-

-

-

3

2.66

0.0034

3

2.66

0.0029

2

3.74

0.0035

2

3.74

0.0045

1

1.90

0.0035

1

1.94

0.0059

-8.9003

-8.54

0.153E+03

0.185 E+03

The EXAFS functions for the individual component interactions (Figure
22B) add to the composite EXAFS function of the best fit model (Figure 22A). In
the Fourier transform of the experimental EXAFS spectrum and fit NifB-co
(Figure 22C), the second shell Fe-S interaction can be observed as a shoulder
around 4.1 Å to the second shell Fe-Fe interaction at 3.74 Å. Again, this validates
the inclusion of a component representing the second shell Fe-S interactions as
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part of the fitting process. A key objective of the current work is to unambiguously
determine the number of ligands to the cluster. Thus, determining the total
number of first shell Fe-S interactions is important. Fitting routines and search
profiles indicate N = 5 as best fit for number of first shell Fe-S interaction for both
NifB-co (Figure 23) and NifB-co●DTT●NifX.
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Figure 22 : EXAFS Spectrum and Fourier Transform for NifB-co
Shown are the (A) collected and calculated EXAFS spectra, (B) EXAFS spectra including the
deconvoluted fit components, and (C) Fourier transform of collected and calculated EXAFS
3
spectra. The calculated spectrum was derived from the k weighted EXAFS equation in Equation
2.
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Figure 23 : Search Profile for Number of First Shell Fe-S Interactions in NifB-co
Shown is a two dimensional contour map of the N vs. R search profile for the first shell Fe-S
interaction in Sample1. A color contour is used to represent the F-value calculated by Equation 4.
The center green circle represents the region that best fits the EXAFS data.

These results suggest the presence of 5 total Fe-S interactions around the
first shell of each Fe atom. In the Fe6S9C structural model for NifB-co, this would
mean that three of the five Fe-S interactions (N = 3) are contributed from S atoms
within the cluster and the remaining two (N = 2) are from S atoms as part of
ligands. If the ligands contribute a total two first shell Fe-S interactions per Fe
atom, and there are six total Fe atoms, then a total of twelve Fe-S interactions
must be present from ligands. With each DTT molecule having two S atoms, the
simplistic interpretation of these results would imply that there are six DTT
molecules ligated around NifB-co for the sample without NifX. The likelihood and
feasibility of such a structure is discussed below.
Samples Containing All Selenol Ligands Suggest Six Fe-ligand Interactions
Samples 3, consisting of NifB-co bound with DSeT instead of DTT (NifB-
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co●DSeT), and sample 4, consisting of NifB-co● DSeT bound to SeCys-NifX
(NifB-co●DSeT●SeCys-NifX), contained only ligands with Se instead of S and
were used for the goal of distinguishing first shell Fe-Se interactions from ligands
or those within the cluster. The first shell Fe-Se interaction distance and DebyeWaller factor were referenced from past experiments that examined the binding
of selenol to FeMo-co (16). If the above interpretation of twelve total binding sites
holds true, then a value of N = 2 for Fe-Se and N = 3 for first shell Fe-S should
best fit for NifB-co●DSeT. EXAFS spectra were obtained for both NifB-co●DSeT
and NifB-co●DSeT●SeCys-NifX and the data was fitted by a similar process as
before with six components as shown in Table 3.
Table 3 : Curve Fitting Parameters for Samples Containing Only Selenol Ligands
EXAFS curve fitting parameters where N is the number of backscattering atoms, R is the distance
between absorbing and backscattering atoms, σ is the Debye-Waller factor, ΔE0 is the
photoelectron threshold energy, and F is the goodness of fit as calculated by Equation 3.
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NifB-co●DSeT
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Fe-S (2

nd
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Fe-Se
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Fe-Fe (1 Shl)
Fe-Fe (2

nd

Shl)

Fe-C
ΔE0 (eV)
F

NifB-co●DSeT●SeCys-NifX
2

2

2

2

N

R (Å)

σ (Å )

N

R (Å)

σ (Å )

3

2.2429

0.0036

3

2.2345

0.0071

3

4.3994

0.0058

3

4.4006

0.0057

1

2.4247

0.005

1

2.398

0.0035

3

2.6591

0.0026

3

2.6456

0.0033

2

3.726

0.0039

2

3.7137

0.0048

1

1.9496

0.0015

1

1.9601

0.0047

-1.306

-2.5704

0.317 E+03

0.52 E+03

While the analysis of data for both of these samples corroborated N = 3 for the
first shell Fe-S interaction (Figure 24A), they did not agree with a value of N = 2
for the ligand contributed (Fe-Se) interactions. Instead, a value of N = 1 for Fe-Se
appeared to have the best fit as evidenced by the color contoured search profile
of the data for NifB-co●DSeT (Figure 24B).
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Figure 24 : Search Profiles for Number of First Shell Fe-S and Fe-Se Interactions in NifBco●DSeT
Shown are two dimensional contour maps of the N vs. R search profile for the (A) first shell Fe-S
and (B) Fe-Se interactions in NifB-co●DSeT. A color contour is used to represent the F-value
calculated by Equation 4. The center green circle represents the region that best fits the EXAFS
data.

This result indicates that there is one selenium atom around each Fe atom. In the
Fe6S9C model, this implies that there are a total of six selenium atoms from
ligands, one binding to each Fe atom of NifB-co. For NifB-co●DSeT, six selenium
atoms would be contributed by three DSeT molecules. The data for NifB90

co●DSeT●SeCys-NifX also indicates a total of N = 1 for the Fe-Se interaction.
Curve fitting parameters for these samples are provided in Table 3. The
experimental data and fits for the EXAFS spectra and Fourier transform for NifBco●DSeT are shown in Figure 25.

Figure 25 : EXAFS Spectrum and Fourier Transform for NifB-co●DSeT
Shown are the (A) collected and calculated EXAFS spectra, and (B) Fourier transform of
3
collected and calculated EXAFS spectra. The calculated spectrum is derived from the k weighted
EXAFS equation in Equation 2.

The fits include the second shell Fe-S interaction at 4.4 Å that was indicated by
earlier search profiles as noted earlier. This longer distance second shell Fe-S
interaction is also included in the fits and is visibly present in the Fourier
transformed EXAFS spectrum in Figure 28D.
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Mixed Ligand Samples Suggest One DTT and Four Cys Bound to NifB-co
Samples 5 and 6, composed of SeCys-NifX bound NifB-co in DTT (NifBco●SeCys-NifX) and NifX bound NifB-co in DSeT (NifB-co●DSeT●NifX)
respectively, were prepared to distinguish how many of each type of ligand binds
to the total number of binding sites through discrimination of ligand types. EXAFS
spectra were obtained for both of these samples and are shown (Figure 26A,
Figure 28E) along with the Fourier transform (Figure 26B, Figure 28F) with the
optimized fit example.
Table 4 : Curve Fitting Parameters for Samples Containing Heterogeneous Ligand Types
EXAFS curve fitting parameters where N is the number of backscattering atoms, R is the distance
between absorbing and backscattering atoms, σ is the Debye-Waller factor, ΔE0 is the
photoelectron threshold energy, and F is the goodness of fit as calculated by Equation 3.

Interaction
st

Fe-S (1 Shl)
Fe-S (2

nd

Shl)

Fe-Se
st

Fe-Fe (1 Shl)
Fe-Fe (2

nd

Shl)

Fe-C
ΔE0 (eV)
F

Sample 5

Sample 6

NifB-co●DTT●SeCys-NifX

NifB-co●DSeT●NifX

2

2

2

2

N

R (Å)

σ (Å )

N

R (Å)

σ (Å )

3.33

2.405

0.0062

3.66
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0.0102

3

4.4056

0.0084

0.66

2.408

0.0037

0.33

2.4073

0.0037

3

2.6476

0.0028

3

2.6508

0.0023

2

3.7256

0.0054

2

3.7241

0.0041
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1
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0.336 E+03

0.336 E+03
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Figure 26 : EXAFS Spectrum and Fourier Transform for NifB-co●DTT●SeCys-NifX
Shown are the (A) collected and calculated EXAFS spectra, and (B) Fourier transform of
3
collected and calculated data. The calculated spectrum is derived from the k weighted EXAFS
equation in Equation 2.

These values correspond to four Se atoms from four SeCys of NifX and
two S atoms from a single DTT molecule, for a total of six NifB-co binding sites.
Search profiles illustrate these values with a green circle representing the region
of best fit for the NifB-co●DTT●SeCys-NifX EXAFS spectrum (Figure 27). The
analysis of the spectrum for NifB-co●DSeT●NifX corroborates this ratio and total
number of binding sites with values of N = 3.66 for the first shell Fe-S interaction
and N = 0.33 for the Fe-Se interaction, which represent four Fe-S interactions
from four normal NifX and two Fe-Se interactions from a single DSeT ligand.
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Similar to NifB-co●DSeT, the Fourier transform EXAFS spectra for NifBco●DTT●SeCys-NifX (Figure 26B) and NifB-co●DSeT●NifX (Figure 28F) indicate
a distance of ~4.4 Å for the second shell Fe-S interaction.

Figure 27 : Search Profiles for Number of First Shell Fe-S and Fe-Se Interactions in NifBco●DTT●SeCys-NifX
Shown are two dimensional contour maps of the N vs. R search profile for the (A) first shell Fe-S
and (B) Fe-Se interactions in NifB-co●DTT●SeCys-NifX. A color contour is used to represent the
F-value calculated by Equation 4. The center green circle represents the region that best fits the
EXAFS data.
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Figure 28 : EXAFS Spectra and Fourier Transforms for NifB-co●DTT●NifX, NifBco●DSeT●SeCys-NifX, and NifB-co●DSeT●NifX
Shown are the (A) EXAFS spectrum and (B) Fourier transform for NifB-co●DTT●NifX, (C) EXAFS
spectrum and (D) Fourier transform for NifB-co●DSeT●SeCys-NifX, (E) EXAFS spectrum and (F)
3
Fourier transform for NifB-co●DSeT●NifX. The EXAFS spectra are calculated using the k
weighted EXAFS equation in Equation 2. Note the NifB-co●DSeT●NifX EXAFS spectra was
truncated to 1 > k > 15 for fit optimization.
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Discussion
NifB-co is a key Fe-S cluster that is essential for the biosynthesis of FeMoco and difficult to characterize. The inability to characterize NifB-co by X-ray
crystal diffraction, EPR, mass spectroscopy or elemental analysis means that,
currently, EXAFS is a principle way to structurally characterize NifB-co. Thus, the
work here has utilized distinguishing Se ligands to deconvolute the interactions of
NifB-co contributed by both the cluster and bound ligands. Determining the total
number of NifB-co Fe-S interactions, distinguishing the contribution of cluster
specific from ligand specific Fe-S interaction, and distinguishing the number of
each type of bound ligand are important for a better structural understanding of
NifB-co. The EXAFS experiment performed here presents information on the
total number of ligand binding sites on NifB-co and the number of each type of
ligand that ligates these binding sites. This was done by discriminating ligand
specific and cluster specific interactions through the utilization of selenium
modified ligands in conjunction with normal ligands.
For the 6-Fe NifB-co structural model, the samples containing NifB-co and
DTT with or without NifX indicated a total of twelve ligand based Fe-S interaction.
Interestingly, all samples that contained selenol modified ligands, with or without
the presence of normal ligands, indicated a total of six ligands binding sites. A
hypothetical structure having twelve ligands is most likely not spatially feasible.
Therefore, another explanation for the 2-fold discrepancy may be that in the
absence of Se, the S atoms of thiol ligands bind in a µ2 fashion (Figure 29A).
This would place the S atom in between two Fe atoms, and the Fe-( µ2S)-Fe
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interaction would appear as two first shell Fe-S interactions from the perspective
of each of the Fe atoms of NifB-co. Due to its larger size and slightly lower
electronegativity, selenol ligands may not be able to behave similarly as the thiol
ligands, and thus must bind µ1 to all the Fe atoms (Figure 25B) and force any
present S atoms to do the same.

Figure 29 : Proposed Structures of Ligand Bound NifB-co
Atoms are colored dark grey for C, light grey for H, red for O, green for Fe, yellow for S, and
purple for Se from ligand. The cluster is depicted with a stick model and the ligands are depicted
with a ball and stick model. (A) NifB-co bound to three DTT molecules as in the NifB-co●DTT
sample, where S atoms from ligands bind to two Fe atoms of the cluster in a μ2 manner.(B) NifBco bound to three DSeT molecules as in NifB-co●DSeT, where Se atoms from ligands bind to
only one Fe atom of the cluster.

As mentioned earlier, the second shell Fe-S interaction was included to
improve fitting of the model. The search profile that addressed the presence of
the second shell Fe-S interaction visualized two reasonable fitting “troughs” for all
samples at ~4.1 and ~4.4 Å. This may mean that there is a two ligand binding
mode that switches between two conformations, thus allowing for both of these
wells. While the thiol only samples (NifB-co●DTT and NifB-co●DTT●NifX) fit
better for the ~4.1 Å distance, an interesting shift in distance from ~4.1 Å to ~4.4
Å was observed for all selenol containing samples. For the selenol only samples
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(NifB-co●DSeT and NifB-co●DSeT●SeCys-NifX), this shift may mean that the
presence of selenium has influenced the cluster to prefer the perturbed ~4.4 Å
state. Samples containing both selenol and thiol ligands (samples 5 and 6)
exhibit a much higher Debye-Waller factor likely due to occupation of both
conformational states. To substantiate these explanations, Nuclear Resonance
Vibrational Spectroscopy (NRVS) would need to be performed on 57Fe
substituted enriched samples.
The EXAFS fits for samples 5 and 6 are most interesting, as they both
verify the total number of binding sites as six and also distinguish the contribution
of each type of ligand. Earlier, a four Cys (or SeCys) to one DTT (or DSeT) ratio
was interpreted from the N = 0.66 to N = 0.33 values remaining after subtraction
of cluster specific Fe-S contributions. However, a four Cys (or SeCys) to two DTT
(or DSeT) is also possible. In the case of two DTT ligands per four Cys ligands
from the NifX protein, the DTT would provide only one S atom for binding per
cluster even though it contains two S atoms, but this is unlikely considering the
spatial restriction inside a protein environment. The insight on NifB-co ligand
binding provided in this work will serve to design clever experiments for future
characterization of NifB-co towards developing the understanding of FeMo-co
biosynthesis.
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CHAPTER 4: SUMMARY AND CONCLUSION
Nature is able to fix nitrogen at biologically relevant conditions in contrast
to the extreme temperatures and pressures of the industrial Haber-Bosch
process due to the metal clusters within the Mo-nitrogenase complex that
catalyze the reduction of N2 to NH3. Understanding how the metal clusters are
made and how they are used by the nitrogenase complex may provide insight
towards improving the Haber-Bosch process to meet the needs for the predicted
future growth of the human population. Recent discoveries in the Mo-nitrogenase
field have elucidated the complete structure of the active site metal cluster,
FeMo-co, and have produced a putative mechanism for FeMo-co catalyzed N2
reduction. However, there are still many unknown aspects for synthesis of FeMoco and the complete structures of FeMo-co precursors. The following section will
summarize the topics of this dissertation and suggest future experiments in the
context of understanding FeMo-co biosynthesis and characterization of the
precursors or intermediates in the biosynthesis. This section will conclude with
some of the big unknowns that remain and will likely steer the Mo-nitrogenase
field of study in the future.
Isolation of NifB
In the FeMo-co biosynthetic pathway, NifB catalyzes the synthesis of the
first FeMo-co precursor, NifB-co (1). The elucidation of the mechanism of NifB
catalysis and full structural understanding of NifB-co has been slow to develop
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due to the insoluble and oxidatively sensitive nature of NifB. Purifications of NifB
fused with either a poly-His tag or NifEN have provided some progress into its
functions of synthesizing an early stage intermediate and inserting the central
carbon (2-5). However, due to the relatively low yields and the presence of
detergent for the poly-His-NifB or the presence of NifEN for the fused NifEN-NifB,
the proteins resulting from these purification methods cannot be used to answer
some of the most important questions regarding NifB. These questions include:
1) How does NifB direct radical chemistry to produce NifB-co? 2) Are the Fe4S4
clusters within NifB used to make NifB-co? 3) What is the structure and
composition of NifB-co? 4) Are any other atoms from SAM incorporated into
precursors to end up in FeMo-co? To answer these questions, a form of NifB is
required that is not fused to NifEN and is readily soluble. For this aim, a strain
was constructed to express GST-fused NifB. The GST-NifB is ideal in that it is
not obfuscated by the presence of NifEN while still soluble due to the presence of
GST.
Generating an A. vinelandii Strain That Expresses Readily Purifiable NifB
For the aim of purifying GST-NifB, recombinant DNA and genetic
techniques were used to produce a vector that could simultaneously insert GSTNifB into the A. vinelandii genome along with deleting through double
recombination other genes that are downstream of the nif promoter. The vector
that made this possible contained a sequence composed with a part of the nif
promoter, GST-nifB, ampR and part of nifX. This vector was constructed by
cloning nifB into pET42 followed by stepwise modification of pSTBlue to reshuffle
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ampR and incorporate a segment of the nif promoter, GST-nifB and nifX gene
sequences. Western blot analysis of the extract from the derivative strain from
the transformation, CF002, shows the expression of a protein of appropriate
molecular weight that was apparently fused to GST. Subsequent activity analysis
indicates that the CF002 extract contains active NifB, which is able to
complement UW45 and activate the Mo-nitrogenase complex at levels equal to
that of isolated NifB-co. Small scale purifications were then performed to isolate
GST-NifB from the CF002 extract by means of a GSH-Sepharose column. The
purification yielded the ~85 kDa protein observed earlier by western blot analysis.
Mass spectroscopic analysis confirmed that the purified product was likely GSTNifB.
Characterization of NifB-co
As with NifB, NifB-co characterization has been slow to progress due to
the susceptibility to breakdown by oxidative damage. In addition, NifB-co
transiently exists in the short period between NifB synthesis and NifX transfer to
NifEN. Currently, the only means to isolate NifB-co are through a detergent
utilizing treatment of the K. pneumoniae strain, UN1217, or as bound to NifX
(1,6). The presence of detergent in NifB-co preparations and the inability to
crystalize NifX prevents the characterization of NifB-co by crystallographic X-ray
diffraction. Furthermore, NifB-co is spin silent and cannot be characterized by
advanced electronic magnetic resonance spectroscopies. To date, the only
elaborate characterization of NifB-co have been Fe specific K-edge EXAFS and
57

Fe NRVS based comparisons between NifX bound NifB-co with NafY bound
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FeMo-co (7). A 6-Fe NifB-co model consisting of Fe6S9C was previously
determined to fit the EXAFS data.
Expanding the Past EXAFS Experiment to Further Characterize NifB-co
The NifB-co models used previously to fit the EXAFS data were limited in
accurately characterizing the total number of Fe-S interactions. The data
suggests that there should be more first shell Fe-S interactions, which can most
likely be accounted for by the contributions from ligands bound NifB-co. Thus, the
past EXAFS experiment was expanded to include samples that contain thiol
ligands, selenol ligands or both. In this manner, the total number ligand and
cluster specific interactions can be segregated by fully analyzing as Fe-S and FeSe interactions. For this aim, SeCys modified NifX and selenol analogs of DTT
were used in conjunction with NifB-co. SeCys modified NifX was purified from
Cys auxotrophic E. coli strains transformed with plasmids containing nifX and
grown in the presence of SeCys. Oxidized DSeT was synthesized and reduced
using NaBH4. NifB-co was then isolated from UN1217 extract with buffers
containing either DTT or DSeT. In all, six samples were prepared for and
analyzed by Fe K-edge EXAFS. Search profiles and rigorous fitting routines were
employed to determine that the thiol only ligand samples suggest twelve Fe-S
interactions on NifB-co in contrast to the six Fe-S interactions suggested by all
other, selenol ligand containing, samples. This can be seen in the N = 5 value (or
rather N = 2 after deducting N = 3 due to cluster contributions) of the first shell
Fe-S interaction in the sample containing only NifB-co and DTT, as opposed to
the N = 1 value for the Fe-Se interaction in the sample containing only NifB-co
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and DSeT. This has been attributed to the possible Fe-(μ2S)-Fe binding mode of
the ligand S atoms, which is apparently not possible in the selenol samples due
to the lower electronegativity and large size of Se atoms. Additionally, the
samples containing heterogeneous ligand types indicate a N value ratio of 0.33
to 0.66 and vice versa for the first shell Fe-S and Fe-Se, which matches the
model of 1 DTT and 4 cysteines per NifB-co in the protein bound form of NifB-co.
Future Aims
With a means to isolate NifB, some of the big unknowns can now be
addressed. Ideally, the GST-NifB purification should be optimized to larger scales
to yield higher concentrations of product. Additionally, eluent from the GSHSepharose column should be treated to remove the small molecular weight
products that are likely non-fused GST or native A. vinelandii GST. This could be
optimized by substituting a 100 kDa ultrafiltration membrane in place of the 30
kDa membrane used during previous purifications. Alternatively, a gel filtration
column could be used to resolve the proteins of different size in the eluent from
the GSH-Sepharose chromatographic step. Purified GST-NifB in higher
concentrations should then be used to complement UW45 extracts to reconfirm
the retainment of activity through the course of purification.
Tracking the 14C Methyl Carbon from SAM to NifB-co
The most pertinent question associated with NifB is whether insertion of
the central carbon occurs first in NifB-co, making NifB-co truly the “core” of
FeMo-co. This question can be answered by using GST-NifB in conjunction with
14

C labeled SAM in an in vitro reaction containing NifX (Figure 30). NifX bound to
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NifB-co can be isolated by using a poly-His fused form of NifX through IMAC
purification described in Chapter 3. This could not be accomplished in recent
experiments using NifEN-NifB due to the presence of NifEN. Radiolabel
presence in the NifX bound NifB-co would verify the EXAFS work in Chapter 3
and previous studies, which suggest a Fe6S9C composition for NifB-co, and
would develop the understanding of NifB-co as the first precursor that contains
the FeMo-co central carbon.

Figure 30 : Reaction to Determine Central Carbon Presence in NifB-co
Highlighted in red is the step at which NifB-co can be isolated. NifB fused to NifEN cannot
produce this step and thus cannot probe for the presence of the central carbon in NifB-co.

Crystal structure analysis would greatly contribute to the knowledge of
NifB. GST was intentionally chosen for NifB fusion for its high solubility and ease
for potential crystallizing (8,9). If crystals of GST-NifB could be formed and
analyzed by X-ray diffraction, the peptide environment around the Fe4S4 clusters
and SAM could be investigated towards understanding how NifB directs its
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presumed radical chemistry. Crystal analysis of GST-NifB may even yield
structures of NifB-co or other intermediates from the hypothesized fusion of two
Fe4S4 clusters.
Investigating the Source and Delivery of Fe4S4 Clusters in the Mo-nitrogenase
Biosynthetic System
NifS and NifU may produce Fe4S4 clusters in anaerobic and reducing
conditions (10). Thus, NifS and NifU are the likely sources of the Fe4S4 clusters
for NifB, Fe-protein, NifEN and the DJ1165 derived apo-MoFe-protein (11).
Correlation between Fe-protein activity and NifS and NifU presence implies that
Fe-protein may obtain a Fe4S4 from NifS and NifU. A possible scheme for Fe4S4
cluster placement in the Mo-nitrogenase system would entail Fe-protein delivery
of NifU and NifS derived Fe4S4 cluster. In this scheme, Fe-protein would first
obtain a Fe4S4 from NifS and NifU (Figure 31a). Fe-protein is already known to
bind NifEN and MoFe-protein at the α- and β-subunit interface, thus Fe-protein
may dock onto cluster-less NifEN and MoFe-protein and deliver whole Fe4S4
cluster instead of an electron (Figure 31d, e). Two Fe4S4 deliveries to cluster-less
MoFe-protein may then result in the P-cluster precursors, where subsequent Feprotein electron deliveries may yield the P-cluster (Figure 31f). Fe-protein may
also bind NifB to provide either Fe4S4 clusters (Figure 31b) or low potential
reductive electrons (Figure 31c) towards the synthesis of NifB-co.

107

Figure 31 : Fe4S4 Cluster Delivery Scheme for Mo-nitrogenase Biosynthesis Components
Shown is a proposed scheme for Fe-protein dependent delivery of Fe4S4 clusters to NifB, NifEN
and MoFe-protein. Orange lines represent Fe-protein dependent Fe4S4 cluster delivery, whereas
green lines indicate Fe-protein dependent electron delivery. (a) Fe4S4 cluster synthesized by NifS
and NifU inserted into Fe-protein. (b) Fe-protein delivers Fe4S4 clusters to NifB. (c) Fe-protein
provides electrons for NifB-co synthesis. (d) Fe-protein delivers Fe4S4 clusters to NifEN. (e) Feprotein delivers Fe4S4 clusters to MoFe-protein. (f) Fe-protein provides electrons for P-cluster
maturation

In vitro Mo-nitrogenase activation assays could be performed to probe for
changes in GST-NifB activity due to the addition of NifS and NifU. Subsequently,
solutions containing cysteine and 55Fe with or without NifS and NifU could be
added into the in vitro Mo-nitrogenase activation reaction to probe for a
correlation between NifU/NifS presence and synthesis of 55Fe FeMo-co. A
positive correlation would indicate that clusters from NifS and NifU activity are
being used by GST-NifB to synthesize NifB-co. GST-NifB could then be used in a
cross-linking experiment with Fe-protein, NifS or NifU to obtain evidence for
protein-protein interactions and potentially map interaction sites on the protein
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surface. Standard gel electrophoresis together with matrix assisted laser
desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) could
then be used to identify cross-linked peptides that may be associated.
Future Characterizations of NifB-co
As with NifB, the understanding of NifB-co would greatly benefit from a
crystal structure. This would require the crystallization of NifB-co alone, NifB-co
bound to NifB or NifB-co bound to NifX. Crystallization of NifB-co alone is difficult
due to the presence of detergents in the NifB-co preparations. NifX could
possibly be crystallized if fused to GST. X-ray diffraction characterization of GSTNifX crystals prior to and after being soaked in solutions containing the NifB-co
may then give insight to structure of NifB-co and the interaction between NifX
and NifB-co, although presence of detergent in NifB-co preparations will likely
also hinder this means of characterization. Crystallization of GST-NifX, or GSTNifB, with bound NifB-co is not likely due to the susceptibility of cluster
degradation. Aside from crystal structure analysis, the best means to
characterize NifB-co is through examination of NifB-co synthesis by NifB. The
best way to characterize NifB-co synthesis would be the time dependent freeze
quenching of GST-NifB in the presence of dithionite and SAM. This could then
trap intermediates of NifB-co synthesis that could be examined by EPR and
possibly ENDOR. Specifically, changes in the GST-NifB Fe-S cluster structures
or oxidation states would likely be reflected in the exhibited EPR signal.
Furthermore, 2H and 57Fe ENDOR analysis of freeze trapped NifB-co precursors
could then provide insight as to how the methyl carbon of SAM is turned into the
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carbide that ends up in FeMo-co.
The oxidative lability, transient existence, and diamagnetic nature of NifBco make characterization difficult. Future characterizations will require clever use
of spectroscopically relevant isotopes, such as 57Fe, 33S, 13C, NifX, NifB;
combinatorial reactions with proteins such as NifX or NifB; and chemical based
ligands and reducing agents to capture or change the structure or oxidation
states of the Fe-S clusters of NifB-co for analysis by advanced nuclear and
electronic spectroscopic techniques like Mössbauer, EPR, ENDOR and ESEEM.
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Primer

Sense or
Antisense

Description

Nucleotide
Sequence 5'-3'

011MLJ

Sense

For cloning A. vinelandii nifB into
pSTBlue

CGCATCCAGACC
CTCAACATCC

012MLJ

Antisense

For cloning A. vinelandii nifB into
pSTBlue

TGGTCATGGCGA
CTCTCCTTAGC

028MLJ

Sense

For cloning A. vinelandii nifX into
pSTBlue

GTATCCAGCCCT
ATCATTCG

029MLJ

Antisense

For cloning A. vinelandii nifX into
pSTBlue

GTGTTGTAGTAG
GCCTTGATCC

047MLJ

Sense

For cloning A. vinelandii nifX into
pET15

AACATATGATGT
CCAGCCCGACC
C

048MLJ

Antisense

For cloning A. vinelandii nifX into
pET15

AACTCGAGCTAT
TCGTCCCAGCCT
TC

129JG

Antisense

For cloning A. vinelandii nifB into
pET42 with poly-His

CCCCAAGCTTGG
CCTTGGCCTGCA
G

134JG

Sense

For cloning A. vinelandii nifB into
pET42

AAATCATGATGG
AACTGAGCGTAC
TTGG

158JG

Antisense

For cloning A. vinelandii nifB into
pET42 without poly-His

CCCCAAGCTTTC
AGGCCTTGGCCT
G

180TJC

Antisense

For ampR deletion in pSTBlue to
yield pTC57

CACCCAACTGAT
CTTCAGC

181TJC

Sense

For ampR deletion in pSTBlue to
yield pTC57

AGGCAACTATGG
ATGAACG

186TJC

Sense

For nif promoter insertion into
pTC66 to yield pTC67

AAAGGTACCAGA
TAGGGAACGATG
TCGC

113

244TJC

Sense

For GST-nifB insertion into
pTC69 to yield suicide vector

AAAAACATATGT
CCCCTATACTAG
GTTATTG

250TJC

Antisense

For nifX insertion into pTC67 to
yield pTC69

AAAAACTCGAGG
TGTTGTAGTAGG
CCTTGATCC

294TJC

Sense

For ampR reinsertion into pTC57
to yield pTC66

AAAAAGGTACCA
AAGATATCGTCA
GGTGGCACTTTT
CG

295TJC

Antisense

For ampR reinsertion into pTC57
to yield pTC66

AAAAACGTACGC
AGTTACCAATGC
TTAATCAGTG

303TJC

Antisense

For nif promoter insertion into
pTC66 to yield pTC67

ATCTTTTCATATG
CATAGTTAATTT
CCTCAGGTTGC

362JG

Antisense

For GST-nifB insertion into
pTC69 to yield suicide vector

AGCAGCCTAGGT
ATTAATCAATTA
GT

364JG

Antisense

For recombination screen,
checks 100bp downstream GST
start

TTTCGCCATTTA
TCACCTTC

365TJC

Sense

For nifX insertion into pTC67 to
yield pTC69

AAAAACTCGAGG
ATCAAGGTGAGC
GAAGG

383JG

Sense

For recombination screen,
checks 100bp upstream of Pnif

AATCAGGCTGTC
GCTGTC

384JG

Antisense

For recombination screen,
checks 100bp downstream of
nifX

CCTTCGTGGGTG
ATGTTG
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Plasmid Description

Related
Primers

pET15

Novagen strain containing T7 promoter, Lac operator,
LacI, ampR, poly-His tag

pET42

Novagen strain containing T7 promoter, Lac operator,
LacI, kanR, ampR, GST tag

pJG50

A. vinelandii nifB in frame with GST in pET42, without
poly-His tag

134JG,
158JG

pJG51

A. vinelandii nifB in frame with GST in pET42, with polyHis tag

134JG,
129JG

pMJ50

A. vinelandii nifX in pSTBlue

028MLJ,
029MLJ

pMJ51

A. vinelandii nifX in pET15

047MLJ,
048MLJ

pSTBlue Novagen strain containing T7 promoter, LacZ, kanR,
ampR
pTC50

A. vinelandii nifB in pET15

011MLJ,
012MLJ

pTC57

ampR deleted form of pSTBlue

180TJC,
181TJC

pTC66

ampR reinserted into pTC57

294TJC,
295TJC

pTC67

A. vinelandii nifX recombination segment inserted
downstream of ampR in pTC66

186TJC,
303TJC

pTC69

A. vinelandii nif promoter recombination segment
inserted upstream of ampR in pTC66

365TJC,
250TJC

Suicide
vector

A. vinelandii GST-nifB inserted between nif promoter and
ampR in pTC69

244TJC,
362JG
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Strain

Description

Genotype

Reference

CF001

Nif(-) A. vinelandii strain of DJ1041
background used for GST-NifB
isolation

GSTnifBΩnifHDKENX
ampR rifR

This work

CF002

Nif(-) A. vinelandii strain of DJ1141
transformation used for GST-NifB
isolation

GSTnifBΩnifHDKENX
ΔnifB
ampR kanR

This work

DJ995

Nif(+) A. vinelandii strain used for
holo-MoFe-protein isolation

nifD:poly-His

(1)

DJ1041

Nif(-) A. vinelandii strain used for
NifEN isolation

poly-His:nifE
ΔnifHDK

(2)

DJ1143

Nif(-) A. vinelandii strain used for
apo-MoFe-protein isolation

nifD:poly-His
ΔnifB::kanR

(1)

DJ884

Nif(slow) A. vinelandii strain used
for Fe-protein isolation

UN1217 Nif(-) K. pneumoniae strain used
for NifB-co isolation
UW45

1.

(3)
ΔnifN::mu

Nif(-) A. vinelandii strain used for in ΔnifB
vitro complementation for FeMo-co
synthesis

(4)

(5)

Christiansen, J., Goodwin, P. J., Lanzilotta, W. N., Seefeldt, L. C., and Dean, D. R.
(1998) Biochemistry 37, 12611-12623
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